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Abstract 
Background: Coronary artery disease is a form of cardiovascular disease (CVD) which 
manifests itself in three ways: angina pectoris, acute coronary syndrome and cardiac death. 
Thirty-three people die daily of a myocardial infarction (cardiac death) and 7.5 million deaths 
annually are caused by CVD (51% from strokes and 45% from coronary artery disease) 
worldwide. Globally, the CVD death rate is a mere 4% compared to South Africa which has a 
42% death rate. It is predicted that by the year 2030 there will be 25 million deaths annually 
from CVD, mainly in the form of strokes and heart disease. The WHO compared the death 
rates of high-income countries to those of low- and middle-income countries, like South 
Africa, and the results show that CVD deaths are declining in high-income countries but 
rapidly increasing in low- and middle-income countries. Although there are several risk 
prediction tools in use worldwide, to predict ischemic risk, South Africa does not use any of 
these tools. Current practice in South Africa to diagnose acute coronary syndrome is the use 
of a physical examination, ECG changes and positive serum cardiac maker levels. 
Internationally the same practice is used to diagnose acute coronary syndrome but risk 
assessment tools are used additionally to this practise because of limitations of the ECG and 
serum cardiac markers when it comes to NSTE-ACS.  
Objective: The aim of this study was to systematically appraise evidence on the accuracy of 
acute coronary syndrome risk prediction tools in adults. 
Methods: An extensive literature search of studies published in English was undertaken. 
Electronic databases searched were Cochrane Library, MEDLINE, Embase and CINAHL. 
Other sources were also searched, and cross-sectional studies, cohort studies and 
randomised controlled trials were reviewed. All articles were screened for methodological 
quality by two reviewers independently with the QUADAS-2 tool which is a standardised 
instrument. Data was extracted using an adapted Cochrane data extraction tool. Data was 
entered in Review Manager 5.2 software for analysis. Sensitivity and specificity was 
calculated for each risk score and an SROC curve was created. This curve was used to 
evaluate and compare the prediction accuracy of each test. 
Results: A total of five studies met the inclusion criteria of this review. Two HEART studies 
and three GRACE studies were included. In all, 9 092 patients participated in the selected 
studies. Estimates of sensitivity for the HEART risks score (two studies, 3268 participants) 
were 0,51 (95% CI 0,46 to 0,56) and 0,68 (95% CI 0,60 to 0,75); specificity for the HEART 
risks score was 0,90 (95% CI 0,88 to 0,91) and 0,92 (95% CI 0,90 to 0,94). Estimates of 
sensitivity for the GRACE risk score (three studies, 5824 participants) were 0,03 (95% CI 
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0,01 to 0,05); 0,20 (95% CI 0,14 to 0,29) and 0,79 (95% CI 0,58 to 0,93). The specificity was 
1,00 (95% CI 0,99 to 1,00); 0,97 (95% CI 0,95 to 0,98) and 0,78 (95% CI 0,73 to 0,82). On 
the SROC curve analysis, there was a trend for the GRACE risk score to perform better than 
the HEART risk score in predicting acute coronary syndrome in adults. 
Conclusion: Both risk scores showed that they had value in accurately predicting the 
presence of acute coronary syndrome in adults. The GRACE showed a positive trend 
towards better prediction ability than the HEART risk score. 
Keywords:  acute coronary syndrome, coronary artery disease, risk assessment tools, 
diagnosis, serum cardiac markers, ECG, QUADAS-2. 
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Opsomming 
Agtergrond: Koronêre bloedvatsiekte is ‘n vorm van kardiovaskulêre siekte. Koronêre 
hartsiekte manifesteer in drie maniere: angina pectoris, akute koronêre sindroom en 
hartdood. Drie-en-dertig mense sterf daagliks aan ‘n miokardiale infarksie (hartdood). Daar 
is 7,5 miljoen sterftes jaarliks as gevolg van kardiovaskulêre siektes (51% deur beroertes en 
45% as gevolg van koronêre hartsiektes) wêreldwyd. Globaal is die sterfte syfer as gevolg 
van koronêre vaskulêre siekte net 4% in vergelyking met Suid Afrika, wat ‘n 42% sterfte 
syfer het. Dit word voorspel dat teen die jaar 2030 daar 25 miljoen sterfgevalle jaarliks sal 
wees, meestal toegeskryf aan kardiovaskulêre siektes. Die hoof oorsaak van sterfgevalle sal 
toegeskryf word aan beroertes en hart siektes. Die WHO het die sterf gevalle van hoe- 
inkoms  lande vergelyk met die van lae- en middel-inkoms lande, soos Suid Afrika, en die 
resultate het bewys dat sterf gevalle as gevolg van kardiovaskulêre siekte is besig om te 
daal in hoe-inkoms lande maar dit is besig om skerp te styg in lae- en middel-inkoms lande.  
Daar is verskeie risiko-voorspelling instrumente wat wêreldwyd gebruik word om isgemiese 
risiko te voorspel, maar Suid Afrika gebruik geen van die risiko-voorspelling instrumente nie. 
Huidiglik word akute koronêre sindroom gediagnoseer met die gebruik van n fisiese 
ondersoek, EKG verandering en positiewe serum kardiale merkers. Internationaal word die 
selfde gebruik maar risiko-voorspelling instrumente word aditioneel by gebruik omdat daar 
limitasies is met EKG en serum kardiale merkers as dit by NSTE-ACS kom. 
Doelwit: Die doel van hierdie sisematiese literatuuroorsig was om stelselmatig die bewyse 
te evalueer oor die akkuraatheid van akute koronêre sindroom risiko-voorspelling 
instrumente vir volwassenes. 
Metodes: 'n Uitgebreide literatuursoektog van studies wat in Engels gepubliseer is was 
onderneem. Cochrane biblioteek, MEDLINE, Embase en CINAHL databases was deursoek. 
Ander bronne is ook deursoek. Die tiepe studies ingesluit was deurnsee-studies, 
kohortstudies en verewekansigde gekontroleerde studies. Alle artikels is onafhanklik vir die 
metodologiese kwaliteit gekeur deur twee beoordeelaars met die gebruik van die QUADAS-2 
instrument, ‘n gestandaardiseerde instrument. ‘n Aangepaste Cochrane data instrument is 
gebruik om data te onttrek. Data is opgeneem in Review Manager 5.2 sagteware vir 
ontleding. Sensitiwiteit en spesifisiteit is bereken vir elke risiko instrument en ‘n SROC kurwe 
is geskep. Die SROC kurwe is gebruik om die akkuraatheid van voorspelling van elke 
instrument te evalueer en te toets. 
Resultate: Twee HEART studies en drie GRACE studies is ingesluit. In total was daar 9 092 
patiente wat deelgeneeem het in die gekose studies. Skattings van sensitiwiteit vir die 
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HEART risiko instrument (twee studies, 3268 deelnemers) was 0,51 (95% CI 0,47 to 0,56)  
en 0,68 (95% CI 0,60 to 0,75) spesifisiteit vir die HEART risiko instrument was 0,89 (95% CI 
0,88 to 0,91) en 0,92  (95% CI 0,90 to 0,94). Skattings van sensitiwiteit vir die GRACE risiko 
instrument (drie studies, 5824 deelnemers) was 0,28 (95% CI 0,13 to 0,53); 0,20 (95% CI 
0,14 to 0,29) en 0,79 (95% CI 0,58 to 0,93). Die spesifisiteit vir die GRACE risiko instrument 
was 0,97 (95% CI 0,95 to 0,99); 0,97 (95% CI 0,95 to 0,98) en 0,78 (95% CI 0,73 to 0,82). 
Met die SROC kurwe ontleding was daar ‘n tendens vir die GRACE risiko instrument om 
beter te vaar as die HEART risiko instrument in die voorspelling van akute koronêre 
sindroom in volwassenes. 
Gevolgtrekking: Altwee risiko instrumente toon aan dat albei instrumente van waarde is. 
Albei het die vermoë om die teenwoordigheid van akute koronêre sindroom in volwassenes 
te voorspel. Die GRACE toon ‘n positiewe tendens teenoor beter voorspelling vermoë as die 
HEART risiko instrument. 
Sleutel woorde: akute koronêre sindroom, koronêre hartsiekte, risiko-assessering 
instrumente, diagnose, serum kardiale merkers, EKG, QUADAS-2. 
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CHAPTER ONE: FOUNDATION OF THE STUDY 
 
The aim of this chapter is to orientate the reader to the study in terms of the background and 
complications related to the accuracy of risk prediction tools for acute coronary syndrome. 
An overview regarding the research question, objectives, research design and methodology 
will also be given. 
 
1.1    BACKGROUND 
Coronary artery disease is a form of cardiovascular disease (CVD) which manifests itself in 
three ways: angina pectoris, acute coronary syndrome and cardiac death (Lewis, 
Heitkemper & Dirksen, 2004:809–810). It is estimated that 33 people die daily of a 
myocardial infarction (Heart and Stroke Foundation of South Africa, 2007: 2). There were 25 
827 deaths in South Africa from heart disease in 2010, making it the fourth leading cause of 
death that year (Statistics South Africa, 2010:38).  Of that total, ischemic heart disease 
caused 12 044 deaths (Statistics South Africa, 2010:83). 
 
1.2    MAGNITUDE OF THE PROBLEM  
There are 7.5 million deaths annually from CVD where 51% are caused by strokes and 45% 
are caused by coronary artery disease (WHO, 2012). It is predicted that by the year 2030, 
there will be 25 million deaths annually due to CVD. These deaths will mainly be caused by 
strokes and heart disease (WHO, 2012). Globally the death rate of CVD is a mere 4% 
compared to South Africa with a 42% death rate (WHO, 2011). The World Health 
Organisation (WHO, 2011) compared the death rates of high-income countries against 
middle- and low-income countries, like South Africa, over the past two decades. The results 
show that CVD deaths in high-income countries are declining, but in low- and middle-income 
countries, they are increasing at a rapid rate.  
 
1.3    DESCRIPTION OF THE CORONARY ARTERY DISEASE 
Acute coronary syndrome occurs as a result of myocardial ischemia, which is the lack of 
oxygen to the myocardium (Lewis et al., 2004:809–810). Acute coronary syndrome is a term 
used to denote the acute phase of ischemic coronary artery disease which can be with or 
without the presence of myocardial cell necrosis (Hamm, Heeschen, Falk & Fox, 2006:333). 
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It refers to a spectrum of conditions, namely unstable angina pectoris, ST-elevation 
myocardial infarction (STEMI) and non-ST elevation myocardial infarction (NSTEMI) (Kohli, 
Parajuli, Maskey & Acharya, 2010: 125). ). In unstable angina pectoris, there is no elevation 
in cardiac markers.  A positive ECG can only be noted during an ischemic episode as 
ischemia is reversible (Houghton & Gray, 2003:186). A STEMI develops as a result of an 
untreated ST-segment elevation acute coronary syndrome. An NSTEMI develops as a result 
of an untreated ST-segment elevation acute coronary syndrome (Lewis et al., 2004:810).  In 
an NSTEMI, the ECG shows no abnormality, hence the term “non-ST elevation myocardial 
infarction”. The World Health Organisation (2012) attributes the high percentage of deaths to 
the fact that the low- and middle-income countries are more exposed to risk factors such as 
the use of tobacco, unhealthy diet and stress. In South Africa it has been proven that South 
Africans follow a sedentary lifestyle and this leads to the development of other risk factors 
that can cause heart disease, such as obesity and hypertension (The Heart and Stroke 
Foundation, 2007). The Heart and Stroke Foundation (2007) explains that the magnitude of 
the risk for heart disease should be determined for each individual by assessing the risk 
factors for that individual. Every risk factor increases ones possibility for a future myocardial 
infarction.    
 
1.4    COMPLICATIONS OF ACUTE CORONARY SYNDROME 
There are many complications that can arise from a myocardial infarction, the most common 
being arrhythmias which occur in 80% of patients and this is the most common cause of 
death in myocardial infarction patients (Lewis et al., 2004:814). There are different 
arrhythmias which are described as the disruption of the intrinsic rhythm of the heartbeat 
(American Heart Association, 2012). Congested heart failure is also a frequent complication 
after a myocardial infarction. Congested heart failure occurs when the pumping effort of the 
heart is diminished due to the injury caused to the heart muscle by the myocardial infarction 
(Lewis et al., 2004:814). Other complications are cardiogenic shock which is an acute form 
of heart failure (Ashley & Niebauer, 2004). In cardiogenic shock there is a lack of oxygen 
and nutrients being pumped to tissues as a result of severe left ventricular failure (Lewis et 
al., 2004: 814). 
 
1.5    DESCRIPTION OF INTERVENTION FOR ACUTE CORONARY SYNDROME 
There are several different tools used globally, in combination with history taking and 
physical examination, to assess ischemic risk when a patient presents at a facility with chest 
pain.  These risk assessment tools are: global registry of acute coronary events (GRACE) 
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and thrombolysis in myocardial infarction (TIMI); platelet glycoprotein IIb/IIIa in unstable 
angina; receptor suppression using integrilin (PURSUIT); the history, electrocardiogram, 
age, risk factors, troponin (HEART); and added sex, serial 2-hour ECG, serial 2-hour delta 
troponin (HEARTS3).  
The GRACE and TIMI risk assessment tools are most commonly used internationally 
(Hamm et al., 2011:3009). The reason for this is that both tools have been validated in 
multiple clinical environments (D’Ascenzo, Biondi-Zoccai, Moretti, Bollati, Omede, Sciuto, et 
al., 2012: 508). Research indicates that the GRACE tool is superior to the TIMI because it 
has a greater ability to risk-stratify a patient, thus indicating the long-term risk for recurrent 
ischemia (Carmo, Ferreira, Aguiar, Ferreira, Raposo, Gonc¸alves, et al., 2011: 247). The 
GRACE risk assessment tool assesses the entire spectrum of acute coronary syndrome and 
it has been validated internally and externally (Yusufali, Zubaid, Alsheikh, Al-Mallah, 
Suwaidi, Rashed, et al., 2011:508). Therefore it is seen as the gold standard internationally. 
The HEART risk assessment tool is a newer tool developed in the Netherlands (Fesmire, 
Martin, Cao & Heath, 2012:1829). It was developed to predict all forms of acute coronary 
syndrome, but was found to have drawbacks and so was revised and adjusted to become 
the HEARTS3. The triple-S that was added refers to sex, serial 2-hour electrocardiogram 
(ECG) and serial 2-hour delta troponin (Fesmire et al., 2012:1830). The HEARTS3 was 
developed to identify acute coronary syndrome and myocardial infarction in a 30-day period 
(Fesmire et al., 2012:1829). The HEART tool was found to outperform the TIMI and GRACE 
tools because it assessed patients with undifferentiated chest pain, whereas the TIMI and 
GRACE tools assess patients diagnosed with acute coronary syndrome (Fesmire et al., 
2012:1834). The HEARTS3 risk assessment tool has not been validated to the same extent 
as the GRACE and TIMI tools. A study of the HEARTS3 recommended that the tool needs to 
be tested further.  
Two risk assessment tools, the GRACE and HEART/HEARTS3 are the focus of this study as 
they assess all forms of acute coronary syndrome. PURSUIT and TIMI were not selected for 
study as they only assess unstable angina pectoris and NSTEMI (Chin, Chua & Lim, 2010: 
218). 
 
1.6    PROBLEM STATEMENT 
In South Africa, the reference standard for diagnosing acute coronary syndrome is elevated 
serum cardiac markers (creatine kinase, MB band and troponin) and a positive ECG. Both 
these reference standards have limitations which makes it risky to rely on them only. ECGs 
do not adequately represent the apical, posterior and lateral walls of the left ventricle which 
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may cause a myocardial infarction in these areas being missed (Kumar & Cannon, 2009: 
921).  A normal ECG does not exclude the possibility of unstable angina pectoris and 
NSTEMI (Kumar & Cannon, 2009:921). In 20 to 50% of cases, the initial ECG is non-
diagnostic of an acute myocardial infarction (Kellett, Hirschl, Derhaschnig, Collinson, Gaze, 
Haass, et al., 2004:159). Two thirds of ischemic episodes are clinically silent, hence they are 
unlikely to be detected by an ECG (Hamm, Bassand, Agewall, Bax, Boersma, Bueno, et al., 
2011: 3005). This makes diagnosing unstable angina pectoris difficult at times. It is important 
to make a quick diagnosis because patients benefit significantly from early treatment (Six, 
Backus & Kelder, 2008:192). A missed diagnosis could result in a wrongful discharge and 
ultimately lead to an out-of-hospital sudden death if unstable angina pectoris progresses to a 
myocardial infarction (Six et al., 2008:192). Troponin I and T measurements also have 
limitations as they do not increase for at least six to twelve hours after the onset of a 
patient’s symptoms (Kumar & Cannon, 2009:921). Patients consulting their general 
practitioners with these symptoms during this period could therefore be missed. 
The use of physical examination, history taking and reference standards to diagnose acute 
coronary syndrome are not sufficient, as cardiac markers and ECG findings have limitations 
and drawbacks. These limitations can lead to a false negative result, missed diagnosis and 
subsequent advanced disease and even death. This has been the experience of the 
researcher who noticed that patients who were admitted to a critical cardiac unit for a 
myocardial infarction, had a history of prior visits to their general practitioners. Most patients 
related that they had been physically examined and sent home following negative cardiac 
markers results and a negative ECG. To ensure effective and targeted treatment, 
appropriate prediction tools are needed in addition to the current practice of physical 
examination, history taking and use of reference standards to confirm the presence of the 
disease. The World Health Organisation (WHO, 2012) identifies a need to reduce the burden 
of CVD in low- and middle-income countries and suggests the implementation of several 
interventions. One of these is to identify high risk patients early in the primary phase with the 
use of simple tools like risk prediction charts. Identifying people early may foster inexpensive 
treatment which can prevent many heart attacks. There is a need to increase government 
investment in prevention and early detection of the disease (WHO, 2012). 
No previous studies could be found in South Africa regarding the implementation of these 
risk assessment tools. Based on this fact, on the limitations of reference standards used to 
diagnose acute coronary syndrome, on personal observations and on informal discussions 
held with various stakeholders, it was decided to undertake the current study. 
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1.7   RESEARCH QUESTION 
The research question posed is as follows: 
What is the prediction ability of risk assessment tools in predicting acute coronary 
syndrome in adults? 
 
1.8   RESEARCH AIM 
The research aim of this study is to systematically appraise evidence for the accuracy of risk 
prediction tools for acute coronary syndrome in adults. 
 
1.9   RESEARCH OBJECTIVES 
The objectives of the study are: 
 To estimate the accuracy of GRACE and HEART/HEARTS3 in predicting acute 
coronary syndrome in adults. 
 To compare the accuracy of the two tools in risk prediction of acute coronary 
syndrome in adults. 
 To propose recommendations for a potential risk assessment tool for South Africa. 
 
1.10  RESEARCH METHODOLOGY 
 
1.10.1  Research design  
A research design is the overall plan or blueprint used to address a research question; it 
includes specifications to enhance a study’s integrity (Polit & Beck, 2012:741). A research 
study involves the performance of a systematic review followed by recommendations which 
are formulated to inform best practice. The research design will be discussed in further detail 
in Chapter three of the study. 
1.10.2   Selection criteria 
Types of study 
The studies considered in this review are cross-sectional studies, cohort studies and 
randomised controlled trials investigating the prediction ability of risk assessment tools 
(GRACE and HEART/HEARTS3) to predict acute coronary syndrome.  
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Types of participants 
Studies were included if they reported on participants of any gender, aged 18 years and 
above, with chest pain.  
Setting 
Study or research setting refers to the location of where a study is being conducted (Grove, 
Burns & Gray, 2013: 373). Studies conducted in any setting were included in the review.  
 Index test  
The index test refers to the test whose performance is being evaluated; therefore the index 
test is referred to as the intervention in diagnostic test accuracy reviews (Centre for Reviews 
and Dissemination, 2009). In this review, the two index tests are the GRACE and 
HEART/HEARTS3 risk assessment tools. 
Outcomes 
Studies were considered which compared the results of GRACE or HEART/HEARTS3 to 
results of elevated serum cardiac markers and/or positive ECG. Due to the fact that both 
cardiac markers and ECG findings formed part of the index test, the outcome that was 
reported in the studies was MACE. MACE are major adverse cardiac events that are an 
indirect result of acute coronary syndrome being present. Therefore if one has MACE, this 
serves as indirect proof that acute coronary syndrome is present (Backus et al. 
2010:164).Therefore elevated cardiac markers and and/or positive ECG was not used as the 
outcome because the results might be biased and not allow a true reflection of the index 
tests ability to predict or refute the presence of acute coronary syndrome. MACE was used 
as reference standard in the selected studies 
Reference standards 
The reference standard refers to the best test currently available to confirm the presence of 
a disease. It is the standard against which the index test is compared in a review of test 
accuracy (Centre for Reviews and Dissemination, 2009). 
The reference standards for confirming the presence of acute coronary syndrome (STEMI, 
NSTEMI or unstable angina pectoris) are elevated serum cardiac markers (troponin T and I 
and CKMB) and/or positive ECG. In the various studies MACE is used as the reference 
standard for reasons identified above. MACE serves as indirect proof that acute coronary 
syndrome is present. 
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1.10.3   Search strategy 
Two reviewers, namely Johet van Zyl and Oswell Khondowe, independently performed a 
literature review searching for articles from inception to 2014. The term inception means that 
since this concept of risk assessment tools has been used in the context of articles and 
conference proceedings. The following databases were used: Cochrane Library, Medical 
Literature Analysis and Retrieval Systems Online (MEDLINE), Excerpte Medica Database 
(Embase) and Cumulative Index of Nursing and Allied Health (CINAHL). Search terms were 
“acute coronary syndrome”, “chest pain”, “NSTEMI”, “STEMI”, “unstable angina pectoris”, 
“angina pectoris”, “risk assessment”, “risk stratification”, “risk prediction”, “predict”, 
“accuracy”, “GRACE”, “HEART” and “HEARTS3”. 
1.10.4 Study selection 
The two reviewers selected studies following a three-step study selection process. This 
process is discussed in Chapter Three. 
 
1.10.5   Critical appraisal 
The identified studies that met the inclusion criteria underwent independent assessment of 
methodology quality by the two reviewers. Differences of opinion between the two reviewers 
were resolved by discussion. If no consensus was reached, a third reviewer was consulted. 
The quality assessment was done using the Quality Assessment of Diagnostic Accuracy 
Studies (QUADAS-2) tool (Appendix B). 
1.10.6    Data extraction 
Data was extracted by both reviewers. An adapted data extraction tool (see Appendix C), 
which is available on the Cochrane website, was used (Cochrane Consumers and 
Communication Review Group, 2011:3–7). A pilot study comprised of three selected studies, 
was conducted to determine the feasibility of the study, search range, assessment and 
extraction tools to minimise errors and to ensure reliability and validity of the extraction tool.  
1.10.7    Data analysis and synthesis 
The study results were reported separately for each study. The statistical software Review 
Manager 5.2 was used to create forest plots for each set of study results. The data from 
each study was used to create 2 x 2 contingency tables to divide the study results into true 
negative, true positive, false negative and false positive. The results of the contingency 
tables were used to present estimates of sensitivity and specificity in a table format and 
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illustrated using a forest plot. Data from the forest plot was used to create graph using the 
summary receiver-operating characteristics space for each index test. 
1.11    ETHICAL CONSIDERATIONS 
A systematic review does not use the customary methods of data collection and analysis, 
but it is necessary for the researcher to adhere to certain ethical principles because the 
research project is bound to raise some or other ethical questions. The first ethical principle 
is permission to conduct the review. Ethical approval was sought from the Human Ethics 
Committee at Stellenbosch University, who granted permission to conduct the proposed 
systematic review (see Appendix A). The rigour of the study was ensured by ensuring 
validity and reliability of tools to be used. Validity is defined by Botma, Greeff, Mulaudzi and 
Wright (2010:174) as the degree to which a measurement represents a true value. Reliability 
is defined by Brink, van der Walt and van Rensburg (2012:126) as the consistency, 
repeatability and stability of a measure. In the systematic review, the measures were the 
tools (QUADAS-2 and data extraction tool) used in the critical appraisal and data extraction 
process. Consistency means that the two reviewers use the same appraisal tool and 
consider similar if not identical outcomes. This is termed “interrater-reliability” (Grove, Burns 
& Gray, 2013:390). Reliability is increased by the two reviewers conducting a critical 
appraisal of studies, thus preventing inconsistencies. Internal validity is increased with the 
clearly described literature search. Internal validity is further increased by updating the 
systematic review with any new studies to prevent omission of relevant data. Internal validity 
can be threatened, however, by language bias of the study. The reviewers could only 
consider studies written in English as a result of limited resources, introducing a possibility of 
language bias in the study. Publication bias can occur where there is an overemphasis of 
differences for the publication’s sake. In other words, positive results have priority compared 
to negative results (Brink et al., 2012:87). In this study, publication bias was reduced by 
including “grey” literature such as conference papers.  
 
1.12  OPERATIONAL DEFINITIONS 
1.12.1  Acute coronary syndrome 
Acute coronary syndrome refers to a condition where there is chest pain and/or other 
symptoms caused by the lack of oxygen supply (ischemia) to the myocardium (Medterms, 
2012). The ischemic episode is prolonged and is not immediately reversible. Acute coronary 
syndrome is subdivided into unstable angina pectoris, STEMI and NSTEMI depending on 
the severity of ischemia (Lewis et al., 2004:810).  
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1.12.2  Evidence 
Evidence refers to information used to determine whether or not a statement or observation 
should be trusted (Pearson, Field & Jordan, 2007:50). LoBiondo-Wood and Haber (2010:16) 
identify various levels of evidence that can be used for clinical decision-making and practice 
recommendations. In this study, evidence is drawn from various sources including cross-
sectional studies, cohort studies and randomised controlled trials, subject experts and 
conference proceedings. 
 
1.12.3   Index test 
The index test refers to the test whose performance is being evaluated; therefore the index 
test is referred to as the intervention in diagnostic test accuracy reviews (Centre for Reviews 
and Dissemination, 2009). In this review, the two index tests are the GRACE and 
HEART/HEARTS3 risk assessment tools. 
 
1.12.4   Reference standard 
The reference standard refers to the best test currently available to confirm the presence of 
a disease. It is the standard against which the index test is compared in a review of test 
accuracy (Centre for Reviews and Dissemination, 2009). In this review, the reference 
standard for confirming the presence of acute coronary syndrome (STEMI, NSTEMI or 
unstable angina pectoris) will be MACE. 
 
1.12.5 Risk assessment     
Risk assessment refers to the estimation of the likelihood of the occurrence of adverse 
effects that may occur from exposure to certain health hazards (Risk assessment, 2013).  
 
1.13    CHAPTER OUTLINE 
The research study is divided into the following chapters: 
Chapter One: Foundation of the study 
In the introductory chapter of the research study, the problem statement, research 
objectives, research design, method, quality of data control and ethical principles are 
presented. 
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Chapter Two: Literature review 
The reader is provided with a summary of theoretical and empirical sources to identify what 
is known and not known about acute coronary syndrome and risk assessment tools. 
Chapter Three: Research methodology 
This chapter provides an in-depth discussion of the various sections introduced in Chapter 
One. The reader is orientated to the research design and method as applied to the research 
study. 
Chapter Four: Results 
Data that has been collected, appraised, extracted and synthesised is presented in this 
chapter. 
Chapter Five: Discussion, conclusions and recommendations  
The results of the study are discussed, together with the conclusions and limitations 
identified throughout the study. Recommendations related to the data findings as well as 
nursing practice, education and research are highlighted in this chapter. 
 
1.14 SUMMARY 
It is essential for South Africa to be able to assess whether risk assessment tools have the 
potential to accurately predict acute coronary syndrome in adults. Statistics indicate that the 
death rate due to CVD is increasing rapidly. This research study intends to create and 
produce evidence of the prediction ability of the GRACE and HEART tools, which will be 
transferred by means of recommendations to be used to inform best practice. The evidence 
from this study will make the assessment phase more specific, preventing some patients 
being ‘misdiagnosed’ as a result of limitations of reference standards used to diagnose the 
presence of acute coronary syndrome. The study thus aims to develop recommendations to 
help to enhance the care rendered to patients with acute coronary syndrome. In Chapter 
Two a summary of theoretical and empirical sources will be discussed to identify what is 
known and not known about acute coronary syndrome and risk assessment tools. 
 
1.15 CONCLUSION 
In Chapter One, an introduction and rationale for the research study was provided. The aim, 
objectives, research methodology and ethical considerations of the study were outlined. 
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Chapter Two will discuss the literature related to acute coronary syndrome in adults and risk 
assessment tools used to predict the presence of the disease. 
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CHAPTER TWO: LITERATURE REVIEW 
 
2.1   INTRODUCTION 
In Chapter One a basic outline of the study was provided, including the research question 
and the research objectives to be explored. Chapter Two will focus on discussing the 
existing body of knowledge concerning acute coronary syndrome and risk assessment tools. 
 
2.2   LITERATURE REVIEW 
A literature review can be described as a written presentation of what one finds when 
reviewing literature (Grove et al. 2013:97). A literature review provides a study with a 
background to the problem being studied (Grove & Burns, 2011:189). Polit and Beck 
(2012:732) define a literature review as a critical summary of research that is based on a 
topic of interest. It is prepared so that a research problem can be placed into context.  
The purpose of this literature review is to examine: 
 Acute coronary syndrome. 
 The South African and international standards used to diagnose acute coronary 
syndrome. 
 Which risk assessment tools are available to diagnose acute coronary syndrome. 
 The strengths and limitations of studies done on these risk assessment tools. 
 
 
2.3   METHOD USED TO IDENTIFY RELEVANT LITERATURE 
Polit and Beck (2012:96) describe the process of conducting a literature review as similar to 
that of a full study. The process includes a question, a plan to gather information and a plan 
to analyse and interpret that information. 
 
Establishing the question is the first step in the literature review process. The question is 
similar to the one created for the study (Polit & Beck, 2012:96). The question is therefore: 
 
What is the current state of knowledge on the question about the accuracy of acute 
coronary syndrome risk assessment tools? 
 
Stellenbosch University  https://scholar.sun.ac.za
13 
 
The second step of the review process is to identify databases to be used, as well as the 
search terms. These were the same as for the study, namely Cochrane Library, MEDLINE, 
Embase and CINAHL, with the addition of Google Scholar. Search terms were “acute 
coronary syndrome”, “chest pain”, “NSTEMI”, “STEMI”, “unstable angina pectoris”, “angina 
pectoris”, “risk assessment”, “risk stratification”, “risk prediction”, “predict”, “accuracy”, 
“GRACE”, “HEART” and “HEARTS3”. Once primary source studies were identified, they 
were screened for relevance and appropriateness. The applicable studies were evaluated 
and information retrieved for the literature review. 
 
 
2.4   DEFINING CONCEPTS 
Acute coronary syndrome : Lewis et al., (2004:810) define acute coronary syndrome as a 
lack of oxygen supply to the heart muscle which is prolonged and not immediately reversible. 
 
Risk assessment : Risk assessment is defined as the estimation of the likelihood that an 
adverse effect may occur if exposed to a health hazard (Risk assessment, 2013).  
 
Risk assessment tool : A risk assessment tool is an instrument that was designed to assist 
with the assessment and evaluation of risk in order to allow one to make a more informed 
decision (Risk assessment, 2013).  
 
Standard : A standard refers to a rule or principles that are used as the basis for judgement 
(Standard, 2014). 
 
  
2.5   FINDINGS FROM THE LITERATURE 
The literature to be described in this chapter begins with the normal anatomy of the coronary 
circulation system. Acute coronary syndrome is then discussed in-depth with regard to the 
etiology, pathophysiology and epidemiology of the disease. The researcher then introduces 
the South African standard used to diagnose acute coronary syndrome, followed by a 
discussion of the international standard. Finally, the researcher describes the gap that was 
identified between physician risk estimation and risk assessment tools. 
 
2.5.1  Anatomy: coronary circulation 
The heart muscle requires a rich blood supply; this is supplied by the left and right coronary 
arteries. These coronary arteries separately arise from the aortic sinus at the aorta’s base 
(Aaronson, Vard & Conolly, 2013:8). This opening (sinus) in the aorta is known as the 
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coronary ostium and allows blood to be supplied to the coronary arteries (Manacci, 
2013:146). 
The right coronary artery runs between the pulmonary trunk and the right atrium of the heart 
to the anterior ventricular sulcus. The right coronary artery then descends to supply the 
lower parts of the heart muscle by dividing into two sections, the posterior descending and 
right marginal branches (Aaronson et al., 2013:9). The left coronary artery runs behind the 
pulmonary trunk and between it and the left atrium. The left coronary artery then divides into 
three sections, namely circumflex, left marginal and anterior descending branches 
(Aaronson et al., 2013:9). Natural anastomoses occur between the left and right marginal 
branches and the anterior and posterior descending arteries. These anastomoses are 
unable to maintain myocardial perfusion in an event of one-sided occlusion of the coronary 
arteries (Aaronson et al., 2013:9).  
Most of the left ventricle is supplied by the left coronary artery. The left ventricle supplies the 
greater part of the body with oxygen and nutrient rich blood. When this coronary artery 
becomes occluded it becomes very dangerous for a patient (Aaronson et al., 2013:9). The 
right coronary artery supplies the anterior ventricular node, sinus node and Bundle of His, 
which is part of the electrical conduction system of the heart. Therefore obstruction of the 
coronary artery causes defects in the cardiac conduction system (Lewis et al., 2004:758). An 
example of a conduction problem when the coronary artery is occluded is an anterior 
ventricular block or slowed heart rate (Aaronson et al., 2013:9). 
The coronary circulation system can develop a good collateral system if required in a patient 
with ischemic heart disease, where a branch or branches of the coronary arteries become 
occluded (Aaronson et al., 2013: 9). This collateral circulation occurs when there are arterial 
anastomoses. This is when arteries and arterioles merge and form an alternative blood 
supply pathway due to another being occluded (Aaronson et al., 2013:11). If occlusions of 
coronary arteries occur slowly over time, the collateral circulation is well formed. Clinically it 
has been proven that younger individuals have more severe myocardial infarctions as a 
result of poor collateral formation (Lewis et al., 2004:801). 
2.5.2   Description of acute coronary syndrome 
Acute coronary syndrome is a term used for a condition brought on by a sudden and 
reduced blood flow to the myocardium (Hamm et al., 2006: 333). Acute coronary syndrome 
development starts in the coronary artery when an unstable, lipid rich substance known as 
plaque, ruptures or erodes. This lipid rich substance is referred to as atherosclerosis. 
Platelets will adhere to this area and a fibrin clot will form and trombonin formation is 
Stellenbosch University  https://scholar.sun.ac.za
15 
 
activated (Manacci, 2013:253). Acute coronary syndrome encompasses a variety of clinical 
presentations; the manifestations follow the disruption of coronary arterial plaque. The 
thrombosis mobilises, causing various degrees of obstruction in the coronary artery affecting 
myocardial perfusion (Hamm et al., 2006:333).  Total occlusion of the coronary artery by the 
thrombosis causes lack of oxygen supply to the myocardial cells (ischemia). The ischemia 
progresses to an infarction of myocardial cells if not immediately treated (Prins, Bote, Smit, 
Wheathes & Neetling, 2008:204).The clinical presentation of a patient depends on the extent 
of myocardial ischemia caused by the occlusion from the thrombosis (Hamm et al., 2006: 
333).  
2.5.3   Aetiology: acute coronary syndrome 
There are a series of non-modifiable and modifiable risk factors related to the development 
of atherosclerosis and the risk of presenting with acute coronary syndrome (Hamm, 
Heeschen, Falk & Fox, 2006:335).  
Manacci (2013:253) identifies the risk factors increasing the likelihood of developing acute 
coronary syndrome as: 
 Non-modifiable – family history of heart disease and menopause 
 Modifiable – smoking, stress, obesity, diabetes, hypertension, hyperlipoproteinemia, 
sedentary lifestyle, high fat and high carbohydrate diet 
 
Hamm et al. (2006: 336) include gender and age under non-modifiable risk factors and they 
describe gender and age as the most powerful and independent predictor of acute coronary 
syndrome development. 
 
2.5.4   Pathophysiology of acute coronary syndrome 
2.5.4.1 Atherosclerosis 
The term atherosclerosis is derived from two Greek words which translate to “hard fatty 
mush”. This indicates that atherosclerosis starts as a soft fatty deposit but over time 
hardens, thus occasionally referred to as “hardening of the arteries” (Lewis, 2004:799). 
Hamm et al. (2006:338) describe atherosclerosis as a chronic and multifocal immune-
inflammatory, fibro proliferative disease of the arteries mainly driven by lipid accumulation.   
Early fatty streak formation appears to be a part of normal development of a human. These 
fatty streaks remain until the age of 10 years old, after which they regress or remain static 
and pose no further harm to the individual. In a minority of individuals these fatty streaks 
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continue to develop into potentially destructive atheromatous plaques (Nowak & Handford, 
2004:222). Coronary heart disease is caused by atherosclerosis; this is where there is a 
build-up of plaque in the lumen of the coronary artery (Marshall, 2011:48). Atherosclerosis is 
the primary cause of acute coronary syndrome.  
2.5.4.2 Myocardial perfusion 
Physiological changes occur when atherosclerosis is present in the coronary arteries. This 
causes problems with myocardial oxygen supply and demand (Rosano, Fini, Caminiti & 
Barbaro, 2008:2551). Myocardial metabolism is oxygen dependent and uses up to 80% of 
oxygen from the coronary blood supply. Coronary blood flow to the myocardium occurs 
during diastole (Nowak & Handford, 2004:253). Lewis et al. (2004:810) explain that 
atherosclerosis causes occlusion in the coronary arteries. When the myocardial oxygen 
demand exceeds the supply, the coronary arteries are unable to supply the heart with 
oxygen and this is termed ischemia (Lewis et al., 2004:810). Myocardial ischemia results 
from the occlusion and this causes impaired myocardial perfusion. The degree of obstruction 
varies and is well tolerated by the body as long as the myocardial oxygen demand is low. 
Ischemia occurs when the demand increases, for example, when individual exercises (Lewis 
et al., 2004:810). When myocardial ischemia is present the term acute coronary syndrome is 
used. 
2.5.4.3 Acute coronary syndrome spectrum 
Acute coronary syndrome is a clinical emergency and needs urgent assessment. Acute 
coronary syndrome is characterised by chest pain, ECG changes and – if myocardial injury 
has occurred – a rise in serum cardiac markers (Dalby, 2001:879). Dalby (2001:879) 
explains further that risk stratification is essential to allow the correct triage of a patient. 
Acute coronary syndrome can either be classified as a STEMI, NSTEMI or unstable angina 
pectoris (Lewis et al., 2004:810). 
ECG 
An ECG is used to diagnose the presence of a STEMI or unstable angina pectoris. In a 
STEMI, a positive ECG is one with an ST-segment elevation of greater than 1mm in two 
contiguous limb leads and 2mm in two contiguous chest leads (Marshall, 2011:53). A 
positive ECG for suspected unstable angina pectoris has T-wave inversion or most 
commonly ST-segment depression (Houghton & Gray, 2003:170–171). A patient who had a 
myocardial infarction before might have a permanent T-wave inversion on the ECG 
(Houghton & Gray, 2003: 185–186). If this patient experiences a myocardial ischemic 
episode, the T-wave turns upright until ischemic episode stops (Houghton & Gray, 2003: 
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185–186). In a NSTEMI there are no ECG changes, hence the term “non ST-elevation MI” 
(Lewis et al., 2004:810). 
Serum cardiac markers  
There are two cardiac markers that are important in diagnosing STEMI or NSTEMI. These 
are creatine kinase (CK), including the MB band, and troponin T and I. The normal CK level 
depends on one’s sex; for women it is 30 to 135 units/L and for men it is 55 to 170 units/L. A 
MB band greater than 3% indicates a STEMI or NSTEMI. Normal values for troponin I are 
0,0 - 0,05 ng/ml or 0,0-0,50 ng/l or less than 10 µg/L (Lewis et al., 2004:817).  The normal 
values for troponin T are <0.01 ng/mL or <14 ng/L or 0–0.1 µg/L (Lewis et al., 2004: 817). 
The three conditions of acute coronary syndrome are portions of the continuum of the clinical 
manifestations arising from a single pathogenic mechanism and therefore may overlap one 
another (Dalby, 2001:880). The ECG findings and results of the blood cardiac markers 
categorise a patient as follows: persistent acute chest pain for 20 minutes or less with ST-
segment elevation on the ECG is diagnosed as ST-ACS. When the blood results of the 
cardiac markers return as positive, troponin I >0,07ng/ml, a diagnosis of STEMI is made 
(Hamm et al., 2011:3004).  
For a patient with an acute chest pain but no ST-segment elevation presenting on the ECG, 
neither T-wave abnormality like T-wave inversion nor ST-segment depression, a diagnosis of 
NSTE-ACS is made. When the blood results of the cardiac markers return as positive, 
troponin >0,07ng/ml, a diagnosis of NSTEMI is made. When the blood results of cardiac 
markers return as negative, troponin I <0,07ng/ml, a diagnosis of unstable angina pectoris is 
made (Hamm et al., 2011:3004). 
Angina is caused by exercise, eating and even stress and can be relieved with rest; this type 
of angina is referred to as chronic stable angina (Mahmoud, Hassanein, Nour, El-Din, 
Elbetagy & Sadaka, 2010:1). Over time the plaque in the coronary artery becomes thickened 
and it ruptures. This leads to platelets aggregating at site of rupture and causes a 
thrombosis to form (Mahmoud et al., 2010:1). The patient will note that his or her symptoms 
for stable angina change in their severity and duration. This state of change is then referred 
to as unstable angina pectoris (Mahmoud et al., 2010:1). Dalby (2001:880) describes 
unstable angina pectoris as a clinical state where there are changes in the pattern of angina 
pain caused by reversible ischemic episodes due to partial occlusion of a coronary artery. 
Cell injury is unlikely when an ischemic episode is reversed (Dalby, 2001:880).  
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2.5.4.4 Signs and symptoms 
Coronary artery disease develops over years, and when symptoms appear then the disease 
process is already well advanced (Lewis, 2004:801). 
The classic signs and symptoms are described by Lincoff (2014:234) as an intense, 
oppressive chest pressure that radiates to the left arm. The signs and symptoms can also be 
described as nearly any discomfort between the nose and navel. Therefore other symptoms 
include pain in the jaw, arm, epigastric and abdominal area. Associative symptoms identified 
by Lincoff (2014:234) include heaviness or burning chest pain radiating to the shoulder, neck 
or back and dyspnoea. There are atypical symptoms experienced by individual, especially 
older women. These symptoms include nausea, vomiting, sweating, breathlessness, light-
headedness and arrhythmias (Lincoff, 2014:234).  
  
2.5.5 Epidemiology of acute coronary syndrome 
2.5.5.1 Prevalence 
The Heart and Stroke Foundation of South Africa (2007) identifies the prevalence of acute 
coronary syndrome as three in every 1 000 people. They also describe the ratio pertaining to 
myocardial infarction related to gender is one female for every two males. South African 
white Afrikaner, Jewish and Asian populations have the highest familial 
hypercholesterolemia carrier rates. This affects one in eight individuals (Prins et al., 2008: 
198). The highest death rates for heart and blood vessel disease occur in the Indian 
population and then in the coloured population. The white and black populations have the 
lowest death rates caused by these diseases. The disease death rate may be similar for 
white and black populations but the pattern is different. The white population pattern of death 
is mostly caused by heart attacks, while the black population death rate pattern indicates 
death mostly being caused by strokes (Heart and Stroke foundation of SA, 2007:4). 
Hamm et al. (2011:3004) identifies NSTE-ACS as more prevalent than STE-ACS but also 
states that it may vary from country to country. Although NSTE-ACS is more prevalent, the 
mortality rate of STE-ACS is higher. When both conditions were compared at six-month 
intervals it was found that the mortality numbers are similar for both conditions. Hamm et al. 
(2007:3004) also assessed the long-term outcomes and found that the death rate for NSTE-
ACS was higher than for STE-ACS.  
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2.5.5.2 Prognosis 
The prognosis related to acute coronary syndrome depends on the occurrence and extent of 
myocardial damage. Patients without persistent ST-elevations and typical rise in cardiac 
enzymes have the lowest incidence of mortality and morbidity. Patients who have 
intermediate complications are those without ST-elevation but with a rise in cardiac 
enzymes. Patients with the worst prognosis are those with ST-elevations and substantial 
myocardial damage (Boersma, Pieper, Steyerberg, Wilcox, Chang, Lee et al., 2000:10). 
 
2.5.6 Standard to diagnose acute coronary syndrome in South Africa 
A diagnosis of STEMI, NSTEMI or unstable angina is made based on a comprehensive 
evaluation of the patient’s history, clinical examination, resting 12 lead ECG and evaluation 
of serum cardiac markers (Dalby, 2001:881).  
Dalby (2001:881) explains that history taking involves enquiring about the pain as well as the 
presence of certain risk factors. The pain type and severity should be assessed because 
pain in acute coronary syndrome is spontaneous in onset, and may vary from mild to 
comprehensive discomfort to a sharp severe pain. The pain location is important as acute 
coronary syndrome pain is usually anterior chest pain, especially substernal, and can include 
radiation to the jaw, shoulder, neck, arms, back and epigastrium (Dalby, 2001:881). The 
interval of the pain must also be assessed. The pain interval is usually brief but may be 
longer than 30 minutes in some individuals. Other symptoms to enquire about are shortness 
of breath, nausea and vomiting as well as diaphoresis (Dalby, 2001:881). Occasionally some 
individuals may experience minimal to no pain and have atypical symptoms with 
accompanying features of acute transient reduction in cardiac output. The symptoms are 
hypotension, tachycardia and/or lethal ventricular tachyarrhythmia’s (Dalby, 2001:882). 
Details of gender and age also need to be recorded, as males over the age of 50 and 
women in menopause have a greater likelihood of developing acute coronary syndrome. 
History about smoking, dyslipidemia, diabetes, family history of CAD and hypertension 
should also be assessed (Dalby, 2001:881). 
A physical examination may deliver minimal to no evidence of the presence of acute 
coronary syndrome as indicated by Dalby (2001:881). Dalby states that there are certain 
findings to consider like the presence of a fourth heart sound or mitral regurgitation murmur. 
Pulmonary congestion may indicate possible transient ischemic myocardial dysfunction. A 
new onset of heart failure, tachycardia, and hypotension with a poor perfusion of the 
peripheral areas as well as cardiogenic shock should increase suspicion. These signs can 
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indicate that a large volume of the myocardium is involved in an ischemic process (Dalby 
2001:881). 
Ker (2003:26) maintains that an urgent resting 12 lead ECG is the first and most important 
test to be performed. An ECG can assist to stratify a patient as one of the following: STEMI, 
NSTEMI or unstable angina pectoris. Dalby (2001:882) further explains that ECG should be 
repeated at intervals of four to six hours. The ECG should be assessed for presence of signs 
of ST-segment depression, transient ST-segment elevation and/or T-wave inversion present 
in two or more contiguous leads (Dalby, 2001:882). Contiguous leads refer to lead groups 
like the inferior leads (II,III and aVF), anterior leads (V1-V6) or the lateral leads (I and aVL) 
(Thygesen, Alpert & White, 2007:2530). A normal ECG does occur in 20 to 26% of patients 
and therefore it is important to obtain further ECG tracings as ECG changes may only 
appear several hours later (Dalby, 2001:882).  
To make a clinical diagnosis of suspected acute coronary syndrome, one cannot rely on 
ECG and clinical symptoms only as they have low diagnostic accuracy (Ramsay, 
Podogrodzka, McClure & Fox, 2006:12). Adding a troponin I to risk-stratify a patient can aid 
the process to diagnose acute coronary syndrome (Ramsay et al., 2006:12). The initial 
evaluation of serum cardiac markers may be within normal ranges, especially when they are 
obtained shortly after onset of chest pain (Dalby, 2001:882). Troponin I has a negative 
predictive value when measured on arrival as time is required for efflux of this marker from 
the injured cardiomyoctes as described by Ramsay (2006:12). When a patient’s cardiac 
markers are normal, it is necessary to obtain a second sample four to six hours, or even 
eight hours, after the onset of chest pain (Dalby, 2001:882). Ker (2003:28) explains that any 
elevation of cardiac markers, namely CKMB and troponin I and T, will increase an 
individual’s risk of acute coronary syndrome. Even minimal elevation is associated with 
increased risk of adverse events (Ker 2003:28).  
A myocardial infarction event can be indicated by the myoglobin cardiac blood marker but 
this marker has been shown to be clinically limited. It has the highest incidence of false-
positive results. Therefore in practice, CKMB and troponin levels are utilised because they 
are specific and sensitive markers of myocardial infarction (Dalby, 2001:882). Raised 
amounts are present as early as four hours after initial onset of ischemic symptoms 
according to Dalby (2001:882). Myocardial infarction is diagnosed when the serum markers 
are above the 99th percentile of values during the first 24 hours after onset (Dalby, 
2001:882). The cut-off value of the 99th percentile for troponin T levels is 0,01ng/ml. There is 
only one type of assay to measure troponin T; thus the value is universal (Mangla, 2012). 
Troponin I’s cut-off value of the 99th percentile varies due to the fact that there are many 
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different assays used to measure troponin I. Here are some of the different assays used, 
together with their cut-off points (Mangla, 2012): 
 DPC Immulite: 0.40 
 Abbott AxSYM: 0.30 
 Bayer ACS:Centaur: 0.15 
 Ortho Vitros: 0.10 
 Bayer ACS:180: 0.07 
 Dade Dimension RxL, second generation: 0.07 
 Beckman Access, second generation: 0.04 
 Byk-Sangtec Liaison: 0.036 
 Dade Status CS: 0.03 
 Roche Elecsys, third generation: 0.01 
To rely only on patient history, physical examination, ECG finding and/or cardiac marker 
results is risky. Each of these tools currently in use has certain limitations. Some symptoms 
patients can present with are not specific and isolated to myocardial ischemia only and can 
lead to misdiagnoses (Thygesen et al., 2007:2527). Thygesen et al. state that some 
symptoms can be attributed to neurological, gastrointestinal, pulmonary and even 
musculoskeletal disorders which are not necessarily cardiac. De Lemos (2008:5) explains 
that elevated troponin levels, even when low, can indicate possibility of other conditions like 
pulmonary emboli, myocarditis, congestive heart failure and even diabetes while left 
ventricular hypertrophy can lead to troponin elevation. Thygesen et al. (2007:2528) also 
point out that when cardiac troponin is elevated in the absence of clinical evidence of 
ischemia, there is a possibility that it can be due to something other than myocardial 
necrosis. The ECG can also indicate something other than myocardial ischemia or infarction 
when there is presence of ST deviations like acute pericarditis, left ventricle hypertrophy and 
left bundle branch block (Thygesen et al., 2007:2529). Other limitations related to ECG 
findings and serum cardiac markers have been described in Chapter One. 
2.5.7 Standard to diagnose acute coronary syndrome internationally 
Patients with acute coronary syndrome present with diverse clinical, ECG and cardiac 
enzyme characteristics. The estimation of risk based only on clinical characteristics is a 
challenge and is imprecise; therefore risk assessment is necessary to guide triage and 
management strategies (Fox, Dabbous, Goldberg, Pieper, Eagle, Van de Werf et al., 
2006:1091). Quantitative assessment of risk is useful to guide clinical decision-making. 
Several scores have been developed to estimate ischemic risk (Hamm et al., 2011:3009). 
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The American College of Cardiology and American Heart Association guidelines highlight 
three commonly used risk assessment models to manage acute coronary syndrome 
patients. The three models are GRACE, TIMI and PURSUIT (Chin et al., 2010:217). For the 
purpose of this literature review, only the GRACE and HEART risk assessment tools were 
explored. TIMI and PURSUIT risk scores were excluded from this review as neither of these 
tools assess the entire acute coronary syndrome spectrum. 
2.5.7.1   GRACE  
The GRACE programme was created in 1999. The purpose of creating the programme was 
to attempt to resolve uncertainties regarding acute coronary syndrome and to define how a 
patient should be treated, as well as to describe the characteristics of the outcomes for these 
patients (Fox, Eagle, Gore, Steg & Anderson, 2010:1095).  The GRACE tool was published 
in 2003 (Chin et al., 2010:217) and was created from an international registry across the 
acute coronary syndrome spectrum (Marshall, 2011).  It was created to assess all forms of 
acute coronary syndrome; unstable angina pectoris, STEMI and NSTEMI (Chin et al., 
2010:217) and to determine the probability of myocardial infarction or death in hospital (Chin 
et al. 2010:217). The originators of the GRACE programme aimed to narrow the gap that 
exists between evidence and clinical practice regarding acute coronary syndrome patients 
(Fox et al., 2010:1095).  
An observational cohort study was conducted in 123 hospitals in 14 different countries. The 
first 10–20 patients admitted with suspected acute coronary syndrome every month were 
included and traced over a period of time (Fox et al., 2010:1095). The study provided a 
reference standard to be used to describe the characteristics, management and outcomes of 
patients with acute coronary syndrome (Fox et al., 2010:1097). The study also looked at 
influences in the variation of care given to individuals assessing the impact on outcomes. It 
examined factors such as geography, resource availability and the adherence to evidence-
based guidelines. The result of this study was the identification of a treatment paradox (Fox 
et al., 2010:1098). It was discovered that those doctors who did not use routine risk 
stratification had patients with lower risk receiving more evidence-based care and treatments 
than did those with high risk. This proved that objective risk stratification tools needed to be 
used and were of great importance (Fox et al., 2010:1098).  
The GRACE risk model was then translated into guidance both nationally and internationally 
and adopted by bodies like the European Society of Cardiology, American College of 
Cardiology, American Heart Association, SIGN guideline and the National Institute for Health 
and Clinical Excellence (Fox et al., 2010:1098). Further studies conducted compared the 
GRACE risk assessment tool to other tools. The GRACE performed extremely well and the 
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National Institute for Health and Clinical Excellence proposed that the GRACE tool be 
applied immediately upon patient presentation (Fox et al., 2010:1098). The GRACE 
programme involved 247 hospitals, and 102 341 patients in 30 different countries assessing 
the entire spectrum of acute coronary syndrome, and was thus a well validated tool. The tool 
provides an opportunity for care delivery to patients with acute coronary syndrome being 
improved by defining patient characteristics and outcomes (Fox et al., 2010:1099). The 
GRACE tool was revised and a second tool was published in 2004 to determine death in a 
six-month period (Chin et al., 2010:217). 
The GRACE tool assesses the following aspects:  age, systolic blood pressure, heart rate, 
Killip class (to assess heart failure), creatinine levels, cardiac arrest on admission, elevated 
cardiac enzymes and ST-segment deviation (Marshall, 2011). It is complex to use because it 
requires a computer programme. According to previous research findings, the GRACE risk 
assessment tool is superior to the TIMI and PURSUIT tools because it has a greater ability 
to determine long-term risk (Carmo et al., 2011:247).  
2.5.7.2    HEART 
Six et al. (2008:191) found difficulties in excluding NSTE-ACS in the emergency room 
because of a lack of ECG changes and lack of increased cardiac marker levels. They 
believed that early diagnosis is critical for a patient to benefit from early treatment. In the 
Netherlands, resident doctors were evaluating patients in the emergency room. They would 
then discuss their findings with their supervisor regarding patient history, risk factors, ECG 
and cardiac marker levels. Based on this, a decision would be made to admit or discharge a 
patient (Six et al., 2008:191). Six et al. found that non-specific chest pain patients were being 
misdiagnosed when presented with NSTE-ACS which resulted in adverse outcomes. They 
wanted therefore to create a new risk assessment tool. Initially they wanted to determine the 
factors that made a doctor decide to admit a patient, and the predictors for acute myocardial 
infarction, death and the need for revascularisation (Six et al., 2008:192). All patients 
admitted in a three-month period were included in the study, with data gathered from a 265-
bed community hospital. Six et al. (2008:92) decided that the different predictors – based on 
medical experience and medical literature of primary end points – would be history, ECG, 
age, risk factors and troponin I. The acronym HEART was created with the first letter of each 
of the predictors (Six et al., 2008:192).  
The HEART risk assessment tool was developed in the Netherlands obtaining a score 
between zero and ten points based on aspects of the acronym. Each aspect was allocated 
zero, one or two points and the total was calculated at the end of the allocation process. It 
was developed to predict acute coronary syndrome (Fesmire et al., 2012:1830). The study 
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included 122 patients. A total of 29 patients reached one or more end points in a three-
month period. Of these, 16 patients were given an acute myocardial infarction diagnosis, 14 
went for percutaneous coronary intervention, six went for coronary artery bypass graft and 
two died (Six et al., 2008:193). Six et al. (2008:196) performed a literature search assessing 
the other tools used for NSTE-ACS and found that neither were applicable to their situation. 
They therefore developed a new tool to trial.  
Literature shows that the common tools used were TIMI, GRACE and PURSUIT. These risk 
assessment tools had a scientific basis but they could not effectively differentiate chest pain 
of patients with low to moderate risk for adverse outcomes. According to Six et al. 
(2008:196), TIMI and PURSUIT are designed for high-risk patients who would benefit greatly 
from aggressive therapy. In addition, PURSUIT was created before the use of troponin 
assays. The limitation of GRACE was that it requires the use of the internet to calculate a 
score. Although TIMI uses a simple calculation, it uses binary choices which do not take the 
existence of grey areas into consideration (Six et al., 2008:196). The advantages identified 
by Six et al. (2008:196) of the HEART risk assessment tool were firstly, that it facilitated 
communication and decision-making between residents and supervisors. The findings from 
their study further showed that a HEART score of zero to three identified a patient as having 
a 2,5% risk of developing adverse outcomes and thus early discharge of patients was 
recommended. A HEART score of four to six indicated that a patient has a risk of 20,3% of 
developing an adverse outcome. These patients needed to be admitted for further 
investigation. A HEART score of seven or more indicated that a patient has a 72,7% risk of 
developing an adverse outcome and such patients would require immediate aggressive 
treatment (Six et al., 2008:196).  
The HEART score required further validation. Backus, Six, Kelder, Mast, van den Akker, 
Mast et al. (2010:164) performed a study of various subgroups to confirm the findings from 
Six et al.’s study from 2008. A total of 2 161 patients were admitted to four different sites. 
There were 910 patients admitted for chest pain, of which 30 were non-evaluable, so 880 
patients remained for inclusion in the study (Backus et al., 2010:166). Within six weeks, a 
total of 158 patients (17,95%) had an adverse outcome and 92 patients (10,45%) were 
diagnosed with acute myocardial infarction. Thirteen patients (1,48%) died (Backus et al., 
2010:166). Backus et al. explain that, compared to the other three commonly used scores, 
the HEART score relies heavily on patient history. Whereas the other methods do not 
classify patient history at all, HEART classifies history numerically. Patients whose history is 
non-suspicious, thus giving a total score of zero for history, have a negative predictive value 
of 95,8%. A patient with a score of two for history has a positive predictive value of 44,4% 
(Backus et al., 2010:168). 
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Fesmire et al. (2012:1830) observe that the GRACE and TIMI risk assessment tools are 
applied to emergency room patients with great success, having been developed to predict 
adverse outcomes in already diagnosed acute coronary syndrome. HEART, on the other 
hand, was created to diagnose undifferentiated patients with chest pain. The HEART risk 
assessment tool was found to outperform TIMI and GRACE. These findings were reported at 
the Congress of the European society of Cardiology in 2010 (Fesmire et al., 2012:1834).  
The HEART risk assessment tool was later found to have drawbacks and was adjusted to 
become the HEARTS3 (Fesmire et al., 2012:1830). This tool was developed to identify acute 
coronary syndrome and myocardial infarction in a 30-day period (Fesmire et al., 2012:1830). 
A study confirmed that the HEARTS3 outperformed HEART, and could reliably risk-stratify a 
patient with chest pain as acute coronary syndrome in 30 days (Fesmire et al., 2012:1863). 
However, according to Fesmire et al. (2012:1863), the HEARTS3 has one limitation: it uses 
complex scoring which makes memorising the score difficult when compared to the HEART 
scoring tool. Unfortunately only one study has been done on the HEARTS3 risk assessment 
tool. 
 
2.5.8 Physician risk estimation versus risk assessment tool 
Approximately 6% of patients are discharged from the emergency unit of a hospital with a 
missed diagnosed myocardial infarction (Ramsay et al., 2006:12). A study was concluded in 
2009 by Yan, Yan, Huynh, Casanova, Raimondo, Fitchett et al., to examine patient risk 
assessment by a physician, in relation to treatment and objective risk-score evaluation. The 
results from their study proved that several well-established and powerful prognosticators 
were not considered by physicians while estimating a patient’s risk. This caused a risk-
treatment paradox. Those who were deemed high risk by physicians would receive 
aggressive therapy. But the GRACE, PURSUIT and TIMI risk scores identified certain 
patients as having been incorrectly risk-stratified by the physician as low risk, while they 
were actually intermediate to high risk. These individuals did not receive the aggressive 
therapy which they should have received (Yan et al., 2009:376). The researchers came to 
the conclusion that risk scores are superior to risk assessment by physicians, and that 
without the use of these risk scores, accurate and comprehensive integration of numerous 
prognostic factors is difficult to achieve (Yan et al., 2009:377). Therefore risk assessment 
tools are a valuable adjunct to clinical judgement (Yan et al., 2009:376).  
A further study was done in 2013 to assess the treating physician’s initial diagnostic 
impression of a patient of possible acute coronary syndrome versus definite acute coronary 
syndrome. The researchers found that the diagnostic impression by physicians influenced 
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the timely delivery of evidence-based therapies (Bajaj, Goodman, Yan, Bagnall, Gyenes, 
Welsh et al., 2013:202). In this study, the predictive accuracy of the GRACE risk scores as 
well as the outcomes, were assessed in relation to the diagnostic impression of possible 
acute coronary syndrome and definite acute coronary syndrome made by the treating 
physician. There were a total of 16 618 patients, of whom 11 152 were diagnosed as definite 
acute coronary syndrome with 5 466 diagnosed as possible acute coronary syndrome by the 
physician. Of the 5 466 with possible acute coronary syndrome, 76% received a final 
diagnosis of acute coronary syndrome. The patients in the possible acute coronary 
syndrome group had a greater rate of myocardial infarction, heart failure and pulmonary 
oedema than those in the definite group (Bajaj et al., 2013:205). These patients also had a 
greater GRACE risk score than those in the definite acute coronary syndrome group as 
stratified by physician; these were the individuals who less frequently received the evidence-
based therapies within 24 hours of admission (Bajaj et al., 2013:205). The researchers 
concluded that the GRACE risk assessment tool provided accurate risk assessment 
regardless of what the initial diagnostic impression of the treating physician was (Bajaj et al., 
2013:206). This study proved that risk assessment using risk assessment tools delivered 
more accurate results than without the tools.  
A study to determine prognostic value beyond the patient risk assessment by the treating 
physician, enrolled a total of 1 728 patients (Yan, Yan, Tan, Casanova, Labinaz, Sridhor et 
al., 2007:1072). The physician had to categorise patients into low-, intermediate- and high-
risk categories for acute coronary syndrome as based on medical history, physical 
examination and laboratory findings, which included troponin levels and ECG finings (Yan et 
al., 2007:1073). Then a risk was calculated for each patient with the GRACE, PURSUIT and 
TIMI risk assessment tools. The endpoint measured was death. Physician risk categorisation 
was compared to that of risk scores (Yan et al., 2007:1074). The results were that the 
treating physician’s high-risk group was three times more likely to die than the low-risk 
group. Those from the TIMI’s high-risk group had a five-fold risk of death compared to the 
TIMI’s low-risk group. The results for the GRACE and PURSUIT tools were even higher. 
Those in the high-risk groups for both tools had a 10 to 15 times higher mortality rate than 
those of the low-risk groups for both tools (Yan et al., 2007:1074). From this evidence, it is 
noted that all three risk scores provided more accurate and prognostic information than did 
the risk assessment by the treating physician. Both the GRACE and PURSUIT risk 
assessment tools were analysed as continuous variables; the risk assessment done by the 
physician failed to deliver any incremental prognostic value (Yan et al., 2007:1074). 
Therefore the researchers concluded that both these tools were more accurate in predicting 
outcomes and were able to deliver additional prognostic value beyond the global risk 
Stellenbosch University  https://scholar.sun.ac.za
27 
 
assessment currently used by physicians. Risk assessment tools were found to refine risk 
stratification and assist in decision-making, thus improving acute coronary syndrome patient 
care (Yan et al., 2007:1078). This study also proved that the GRACE and PURSUIT tools 
could be safely used to deliver good results. 
To evaluate whether care provided to acute coronary syndrome patients correlated with 
perceived and calculated risk, another study was performed to explore how well clinicians 
estimated risk of death, an adverse outcome, among acute coronary syndrome patients 
(Chew, Junbo, Parsanage, Kerkar, Sulimov, Horsfall & Mattchoss, 2013:209). Physicians 
were asked to estimate the risk of ischemic events for 1 542 patients to develop myocardial 
infarction or acute coronary syndrome or die (Chew et al., 2013:302). The GRACE tool was 
used to calculate a score for death in six months. The findings from the physician risk 
assessments were that they overestimated the risk for death at six months for the GRACE 
low-risk score patients, and underestimated the risk of death for the GRACE high-risk score 
patients (Chew et al., 2013:303). The results showed that mortality at six months was higher 
for the physician’s low-risk group than for the physician’s high-risk group. The low-risk 
physician’s group was identified as high risk by the GRACE risk score (Chew et al., 
2013:306). Therefore the GRACE risk score had significantly superior discriminatory power 
in comparison to physicians’ risk estimates (Chew et al., 2013:303). This study also showed 
that estimation of risk using the GRACE risk assessment tool was superior to physician risk 
assessment (Chew et al., 2013:306). 
Yan et al. (2007:1076) emphasise that risk scores are clinical tools that must be used as a 
supplement to clinical judgement, not to replace it. For example, risk scoring will score a 
patient with triple vessel coronary artery disease, left ventricular systolic dysfunction 
presenting with angina but with a normal ECG and cardiac markers as low risk, where in fact 
this is a high-risk patient for acute coronary syndrome (Yan et al., 2007:1076). By using risk 
scores and clinical judgement, a more comprehensive and accurate diagnosis can be made 
for a patient with acute coronary syndrome. 
This review of literature showed that diagnosing of patients with acute coronary syndrome 
was more accurately done when physical assessment, cardiac markers and ECG (current 
practice in South Africa) was combined with the use of risk assessment tools (international 
practice). The GRACE and HEART risk assessment tools were selected for reviewing 
because from literature they proofed to be more superior as well having the ability to assess 
the entire spectrum of acute coronary syndrome.  
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2.6 SUMMARY  
Mahmoud et al. (2010:60) comment that the outcomes for patients with acute coronary 
syndrome are poor, although this in an era in which there are modern advances in 
technologies and therapies. In this chapter, the researcher has explored possible reasons for 
these poor outcomes. Acute coronary syndrome is a difficult disease to diagnose. To rely 
only on subjective risk assessment places many patients at risk of adverse outcomes as well 
as risking not receiving lifesaving therapy and treatment within the first 24 hours of 
admission. A clinician or physician should use both subjective and objective data before 
diagnosing a patient with or without acute coronary syndrome, as the first 24 hours are 
crucial for such patients.  
In Chapter Three, the researcher will provide a detailed discussion of the research design, 
method and quality measurement of the study. 
 
2.7  CONCLUSION 
In this chapter, the researcher explored various studies regarding acute coronary syndrome: 
what it is, what causes it, what is the prevalence and prognosis for someone with this 
syndrome. Previous literature was also reviewed and the researcher assessed the method of 
diagnosing acute coronary syndrome in South Africa and its limitations. Risk assessment 
tools used internationally were described and the benefits and limitations of using such tools 
were discussed. The researcher identified the gap that exists between risks assessments 
currently used in South Africa, and risk assessment with the use of risk scores. The 
conclusion made by the researcher is that both subjective and objective risk assessments 
are necessary to complement each other as they both have limitations. 
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CHAPTER THREE: RESEARCH METHODOLOGY 
 
3.1 INTRODUCTION 
In Chapter One, a synopsis of the study was presented. Chapter Three will provide the 
reader with a detailed discussion of the research design, method and quality measurement 
of the study. The steps of the research process will then be described in detail. 
A research project can only be considered successful if the identification and creation of the 
research problem is accurate. Once the problem has been accurately identified, a definite 
plan and presentation of research methods can be decided upon. The research design and 
method describe the method used to solve the research problem.  
This chapter’s purpose is to provide a broad description of the research design and research 
method used to achieve the following objectives: 
 To estimate the accuracy of GRACE and HEARTS in predicting acute coronary 
syndrome in adults. 
 To compare the accuracy of the two tools in risk prediction of acute coronary 
syndrome in adults..  
 To propose recommendations for a potential risk assessment tool for South Africa. 
 
3.2   RESEARCH DESIGN  
A research design is defined by Grove, Burns and Gray (2013:692) as a blueprint required to 
conduct a research study. The blueprint maximises the researcher’s control over factors that 
could affect the validity of the research findings (Burns & Grove, 2011:253). In this research 
study, the research design followed a systematic review format of the Cochrane 
Collaboration handbook of diagnostic test accuracy reviews (Deeks, Wisniewski & 
Davenport, 2013).  
 
3.2.1 Systematic review 
A systematic review was performed in order to explore and describe existing literature 
related to the accuracy of acute coronary syndrome risk prediction tools. A systematic review 
is defined as a rigorous synthesis of research findings, using a systematic process of 
sampling, data collection and a formal protocol (Polit & Beck, 2012:745). 
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Joubert & Ehrlich (2008:69) state that a systematic review is a review where bias has been 
reduced through systematic identification, appraisal, and synthesis and if relevant, statistical 
aggregation of relevant studies based on an identified topic according to a predetermined 
and explicit method. Systematic reviews are conducted to create evidence from several 
high-quality studies which used a similar methodology. A systematic review is usually done 
by a team of experts who use a rigorous synthesis process. The results of a systematic 
review are usually used to create standardised guidelines which are then utilised in 
healthcare practice (Burns & Grove, 2011:24).  
 
3.2.2   Purpose of doing a systematic review 
There has been an explosion in medical and nursing publishing in the last few years and this 
trend is likely to continue. This explosion makes it very difficult to keep up with primary 
research evidence. Over the last few years, internet access to articles has grown 
tremendously and this creates an overwhelming number of articles one needs to explore 
(Hemingway & Breroton, 2009:2).   
Clinicians, nurses and policymakers require access to extensive information which is of good 
quality, effective and appropriate. This need for information can conflict with busy workloads 
and often leads to a lack of necessary knowledge for the people concerned. There may also 
be a number of studies available concerning a specific subject, but each published article 
may provide only limited insight into a problem. When these different articles are synthesised 
into a systematic review, the resulting review can deliver a clear and concise image of a 
problem (Hemingway & Breroton, 2009:2).   
Systematic reviews are necessary to establish the clinical and cost effectiveness of a certain 
intervention. They are also required to ascertain if an intervention is feasible, if it is 
appropriate (ethically or culturally) or if it relates to evidence of experiences. Systematic 
reviews are also required to propose a future research plan when the way forward may be 
unclear (Hemingway & Breroton, 2009:3). A systematic review provides a researcher with an 
overview of many different authors’ articles rather than the opinion of only one author, thus 
decreasing the chance of bias (Hemingway & Brereton, 2009:2). For these reasons, a 
systematic review approach was selected to assess the accuracy of acute coronary 
syndrome risk prediction tools. As previously noted, these risk assessment tools are not 
implemented in South Africa. Recommendations will be made based on the evidence and 
will not reflect any bias on the part of the researcher. 
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3.3   RESEARCH METHOD 
Systematic reviews are often referred to as secondary research (Kitchenham, 2004:1). A 
systematic review necessitates a method or design in gathering and analysing data. 
Grove et al. (2013:711) define a systematic review as a structured synthesis of quantitative 
data from studies. The aim of the synthesis process is to determine the best evidence 
available to enhance evidence-based practice. A systematic review is therefore a structured 
process where a comprehensive synthesis of research literature is carried out with the aim of 
finding the best research evidence available on a certain healthcare question (Grove et al., 
2013:472). The main steps of this process are to initially formulate a research question and 
then to search for evidence related to the question. This involves selecting applicable studies 
based on study-specific criteria. Once the researcher has identified relevant studies, he or 
she is required to assess the methodological quality of studies performed. The researcher 
can then extract data, analyse and synthesise it. The final step in this process is to interpret 
the findings (Wieseler & McGauran, 2010:1240). 
As a result of the need for rigour in construction of a systematic review, a formal scientific 
process has developed, requiring the review to be directed by a systematic review protocol 
(Hemingway & Brereton, 2009:4).  
 
3.3.1 Systematic review protocol 
Systematic reviews begin by defining the review protocol. The protocol specifies the 
research question being addressed and the methods that will be used to perform the review. 
A pre-defined protocol is essential to reduce the possibility of researcher bias (Kitchenham, 
2004:4). 
The components of a systematic review protocol include a background stating the rationale 
for the review, which identifies the research question and the strategy used to search for 
primary studies. This strategy includes the identification of databases, journals and 
conference proceedings to be reviewed. The strategy also indicates the search terms that 
are used. The protocol identifies the inclusion and exclusion criteria to assist the researcher 
with the study selection process. The protocol also specifies the quality assessment method 
that will be used. It identifies the data extraction strategy and describes how the data will be 
synthesised. The protocol also identifies the project timetable which defines the review plan 
(Kitchenham, 2004:4). A systematic review protocol was developed by the researcher for 
this study and the review protocol was approved by the Health Research Ethics Committee 
at Stellenbosch University (See Appendix A). 
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3.3.2 Research question 
A research question can be described as a clear and concise statement created to give 
direction to a study. The statement contains a description of variables or describes a 
relationship among variables (Grove et al., 2013:708). In a systematic review a well-
formulated research question is required (Hemingway & Brereton, 2009:4). A review may 
have more than one question to answer. The question needs to be focused and clear in 
order to facilitate the process of finding material that addresses the specific question 
(Joubert & Ehrlich, 2007:69). A research question can emanate from the direct interaction of 
a healthcare practitioner with patients or from the observations made by a healthcare 
practitioner, or from a patient who asks a question (Botma, Greeff, Mulaudzi & Wright, 
2010:242).  
In evidence-based practice methodology, it is recommended that a systematic review 
question being asked, examine the population of interest, intervention needed, comparison 
of intervention and outcomes needed. This is known as the PICO format (Grove et al., 
2013:474). In this study, the population of interest is adults with acute coronary syndrome. 
The intervention is the risk assessment tools, GRACE and HEART. Initially the comparison 
was going to be made to elevated serum cardiac markers and positive ECG, which are the 
reference standards for diagnosing acute coronary syndrome. However, because these 
elements are part of the index test, the comparison was instead made to major adverse 
cardiac events (MACE). The outcome of interest is the accurate risk prediction of acute 
coronary syndrome. The review question posed for this study is as follows: 
What is the prediction ability of risk assessment tools GRACE and HEART in predicting 
acute coronary syndrome in adults? 
 
3.3.3 Searching for evidence 
The researcher needs to search for relevant studies and the relevance of these studies will 
be based on the review question (Botma et al., 2010:243). To ensure this is an unbiased 
assessment, the researcher must seek to cover all literature in his or her search 
(Hemingway & Brereton, 2009:4). Experts in systematic reviews have different opinions 
about inclusion of unpublished studies and grey literature. Some experts believe that the 
exclusion of such studies will make one’s study biased. Other experts believe that only 
studies with positive outcomes that are published should be included (Hemingway & 
Brereton, 2009:4).  
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Pearson et al. (2007:60) believe that it is very important to create a thorough search strategy 
because a poorly structured strategy may affect the quality of the study. The first step in 
developing the search strategy is to specify the selection criteria that will be used to locate 
studies. The criteria are a necessity as they assist the researcher in narrowing the search 
(Botma et al., 2010:244). Then the researcher can decide on which databases and search 
terms to use. The strategy for identifying grey literature and unpublished articles should also 
be described (Grove et al., 2013:476). The search strategy used in this study will now be 
described.  
3.3.3.1 Search strategy 
The American Dietetic Association (2008:19-20) describes the aim of the search strategy as 
identifying all possible literature relevant to the research question. The strategy used should 
be comprehensive, thus improving the credibility of the review performed and reducing the 
risk of bias (Centre for reviews and dissemination, 2009:19). The Centre for Evidence-Based 
Conservation (2009:6) describes the search process as the identification of a “sample” and 
recommends the use of electronic databases, manual search of unpublished journals and 
the use of grey literature such as conference proceedings to identify this sample. The search 
process must be documented; this ensures transparency and repeatability (Magarey, 
1997:378). 
Two reviewers independently performed a literature review search for articles from inception 
to 2014 by using the following databases: Cochrane Library, MEDLINE, EMBASE and 
CINAHL. Search terms were “acute coronary syndrome”, “chest pain”, “NSTEMI”, “STEMI”, 
“unstable angina pectoris”, “angina pectoris”, “risk assessment”, “risk stratification”, “risk 
prediction”, “predict”, “accuracy”, “GRACE”, “HEART” and “HEARTS3”.  
To increase the precision of the search, terms of the disease were combined with terms of 
the risk assessment tools during the search. The Cochrane handbook for systematic reviews 
of diagnostic test accuracy recommends use of more than one approach when conducting 
searches. In addition to the methodological filter search with terms for the index test and 
disease, reference lists of identified articles were searched for the identification of more 
studies. Authors were also contacted electronically where articles were only published in 
foreign languages, to enquire about English versions. Hand-searching was done to find 
relevant articles in medical and cardiology journals (Cardiology Journal of SA, 2002-2007; 
SA Heart Journal, 2007-2014; The South African Medical Journal, 2003-2014). Cardiology 
conference proceedings from inception to 2014 were also searched for relevant articles 
(American Heart Association, British Cardiovascular Society, European Society of 
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Cardiology, American College of Cardiology and American College of Chest Physicians).  
The search criteria used will now be discussed. 
3.3.3.2     Selection criteria 
Types of study 
The type of studies considered in this review include cross-sectional studies, cohort studies 
and randomised controlled trials investigating the prediction ability of risk assessment tools 
(GRACE and HEART) to predict acute coronary syndrome. Studies investigating the 
prediction ability of risk assessment tools, to determine the presence of acute coronary 
syndrome, were included. Where studies were in foreign language, the researcher made 
efforts to secure an English version. The most recent or completed study was included if 
there was a duplicate publication of the same data. 
Types of participants 
Studies were included if they reported on participants aged 18 years and above and of any 
gender. This age group was selected because CVD affects adults from 18 years onwards in 
low- and middle-income countries (WHO, 2012). The target population included those at risk 
and those with acute coronary syndrome.  
Setting 
Study or research setting refers to the location of where a study is being conducted (Grove, 
Burns & Gray, 2013: 373). Studies conducted in any setting were included in the review.  
Index test  
The index test refers to the test whose performance is being evaluated; therefore the index 
test is referred to as the intervention in diagnostic test accuracy reviews (Centre for Reviews 
and Dissemination, 2009). In this review the two index tests were the GRACE and HEART 
risk assessment tools. 
The risk assessment tools described below are commonly used to predict acute coronary 
syndrome. The GRACE risk assessment tool assesses the following aspects:  age, systolic 
blood pressure, heart rate, killip class (to assess heart failure), creatinine levels, cardiac 
arrest on admission, elevated cardiac enzymes and ST-segment deviation (Marshall, 2011: 
52). Each aspect is scored and the total is determined by adding the different scores. A total 
can be anything between 0 and 258. There are three categories; low risk, intermediate risk 
and the high-risk category (Abu-Assi,Gracia-Acuna, Pena-Gil & Gonzalez-Juanatey, 
2009:642). The threshold for this index test is a GRACE score of < 108 for an in-hospital 
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event (GRACE ACS Risk Score, 2013). Values from 0 to 108 are considered low risk; 
intermediate risk is 109 to 140 and all scores of more than 140 are considered high risk. The 
GRACE risk assessment tool is more complex to use because it requires a computer 
programme to calculate the total (Chin et al., 2010: 217). The HEART risk assessment tool 
gives a score for each aspect; this score can be 0, 1 or 2 points and the total is calculated at 
the end of the assessment. The aspects assessed are history, electrocardiogram, age, and 
risk factors. The total for the HEART ranges between 0 and 10. Scores of 0 to 3 are low risk; 
medium risk is 4 to 6 and high risk is 7 to 10. The HEART risk assessment tool has a 
threshold of < 2 (Six, Cullen, Backus, Greenslade, Parsonage, Aldous, et al., 2013:124). 
Both the GRACE and the HEART risk assessment tools use troponin and ECG to predict 
acute coronary syndrome and this may have a likelihood of bias. For this reason, authors of 
the included articles used MACE as their reference standard. 
Outcomes 
We considered studies that compared the results of GRACE or HEART to those of elevated 
serum cardiac markers and/or positive ECG. Due to the fact that both cardiac markers and 
ECG findings formed part of the index test, the outcome that was reported in the studies 
identified was MACE. MACE are major adverse cardiac events that are an indirect result of 
acute coronary syndrome being present. Therefore if one has MACE, this serves as indirect 
proof that acute coronary syndrome is present (Backus et al. 2010:164). These results were 
presented as estimates of sensitivity and specificity. 
Reference standards 
The reference standard refers to the best test currently available to confirm the presence of 
a disease. It is the standard against which the index test is compared in a review of test 
accuracy (Centre for Reviews and Dissemination, 2009). 
The reference standard for confirming the presence of acute coronary syndrome (STEMI, 
NSTEMI or unstable angina pectoris) in this review was the presence of MACE. 
MACE 
As discussed under the outcomes section of this chapter, the reference standard ECG and 
cardiac markers are what is used to confirm the presence of acute coronary syndrome, but 
due to these forming part of the index test, the results might be biased and not allow a true 
reflection of the index tests ability to predict or refute the presence of acute coronary 
syndrome. MACE was used as reference standard in the selected studies. MACE refers to 
major adverse cardiac events that occur due to the presence of acute coronary syndrome. 
The four of interest in this study were percutaneous coronary intervention (PCI), coronary 
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bypass graft (CABG), acute myocardial infarction (AMI) and death. PCI is described as a 
process of mechanical reperfusion of a thrombotic coronary occlusion. It serves as an 
alternative therapy to surgical intervention (Lewis et al., 2004:821). Lewis et al. (2004:822) 
refers to a CABG as myocardial reperfusion which is the surgical treatment for coronary 
artery disease. CABG is a surgical procedure where there is construction of new blood 
vessels between the aorta and the other major arteries in the myocardium to bypass the 
obstructed coronary artery. Therefore with the new blood flow pathway, oxygenated blood is 
provided to the myocardium beyond the area that has stenosis (Lewis et al., 2004:822). 
Acute myocardial infarction or myocardial infarction refers to irreversible cell death of the 
myocardium due to sustained ischemia caused by thrombotic coronary occlusion. Cell death 
occurs approximately after 20 minutes of sustained ischemia, and the cell death is known as 
necrosis and is irreversible (Lewis et al., 2004:810). The other adverse event is death 
resulting from cardiac causes. 
3.3.3.3 Study selection 
The selection of studies can be seen as a sampling technique (Polit & Beck, 2012:657). 
Burns and Grove (2005:357) stress that the selection must be explicit and sensitive to 
ensure that only studies which are relevant and unbiased are included in the review. Once 
all possible studies had been identified, each study needs to be assessed for eligibility 
against the inclusion criteria. Only then, full text articles of those which meet the inclusion 
criteria are retrieved (Hemingway & Brereton, 2009:4).  The study selection in this review 
was done following a three-step study selection process. The inclusion criteria have been 
described under item 3.3.3.2. 
Two reviewers selected studies that were eligible. The first step was the selection of studies 
based on their titles and abstracts. Each reviewer selected eligible studies for review of the 
full text articles, making use of the selection criteria described above. The second step was 
each reviewer retrieveing the full text articles of the selected  studies and assessing them for 
inclusion based on the selection criteria. Full text articles were also obtained where eligibility 
was unclear from reading the title and abstract only. In the final step, reviewers consulted 
each other regarding the selected articles and a decision was made on which of these 
articles was to be included. Authors of articles were contacted for missing data.  
Disagreements were resolved by discussion. The process of selection of studies is illustrated 
in Chapter Four with the use of the Preferred Reporting Items for Systematic Reviews And 
Meta-Analyses flow diagram (Moher, Liberati, Tetzlaff & Altman, 2009). 
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3.3.4 Critical appraisal 
A critical appraisal is done to assess the methodological quality of an article. It is suggested 
that two or more experts perform the critical appraisal independently of each article and 
make judgement about the article’s quality (Grove et al., 2013:477). A critical appraisal is 
also referred to as the critiquing of literature. This refers to an approach that is organised 
and systematic where research studies are evaluated using a set of established critical 
appraisal criteria. The purpose of this approach is to objectively determine the strength, 
quality and consistency of the study to establish if it is applicable to research (LoBiondo-
wood & Haber, 2010:57). The evidence from primary studies needs to be evaluated to 
determine how much confidence to place in the study’s findings. Studies that are 
methodologically sound are given more weight than weaker methodology studies in coming 
to a conclusion regarding the body of evidence (Polit & Beck, 2012:658). The evaluation of 
study quality might involve the use of quantitative ratings. There are many quality 
assessment scales that have been developed (Polit & Beck, 2012:658). The researcher is 
required to select the most appropriate one for the type of study being conducted. The 
critical appraisal in this study was conducted as detailed below. 
Quality assessment was performed by using the Quality Assessment of Diagnostic Accuracy 
Studies (QUADAS-2) tool (see Appendix B). The tool rates the bias and applicability of 
diagnostic accuracy studies (Whiting, Rutjes, Westwood, Mallet, Deeks, Reitsma, et al., 
2011:529). The QUADAS-2 tool consists of four domains, namely patient selection, index 
test, reference standard, and flow and timing. Each domain assesses the risk of bias. The 
first three domains assess concerns regarding the applicability of the study as well. The tool 
is applied in four phases: summarise the review question, tailor the tool to review and 
produce review-specific guidance, construct a flow diagram for the primary study and assess 
risk of bias and concerns regarding applicability (Whiting et al., 2011:529).  
The chosen studies were subjected to independent assessment of methodological quality by 
the two reviewers. Once the methodological quality was determined, a discussion was held 
between the two reviewers to determine which articles were of sufficiently good quality for 
inclusion. Differences of opinion between the two reviewers were resolved by discussion. If 
no consensus was reached, a third reviewer was available. In the following chapter, the 
results of the methodological quality are illustrated in a table and the results are described. 
3.3.5 Data extraction 
Data extraction refers to the extraction of relevant data about study characteristics, methods 
as well as findings. The data extraction process requires the researcher to develop a data 
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extraction form and a coding manual to guide those who are extracting the data (Polit & 
Beck, 2012:659). The data extraction process ideally is done by two independent reviewers 
(Hemingway & Brereton, 2009:4). The data extraction process for this review is discussed 
below. 
Data was extracted by each of the reviewers independently. An adapted data extraction tool 
(see Appendix C), which is available from the Cochrane website, was used (The Cochrane 
Consumers and Communication Review Group, 2011:3–7). A pilot study comprising of three 
selected trials, was conducted to determine the feasibility of the study, search range, 
assessment and extraction tools to minimise errors and to ensure reliability and validity of 
the extraction tool. Minor changes were made to the original data extraction tool. In the 
method section consumer involvement was removed as it was not applicable to this 
systematic review. In the participant section the geographic location, gender and ethnicity 
was removed as this information was not necessary in this review. The pilot test articles 
were included in the review. Baseline characteristics of included studies were documented in 
tabular format, including participant characteristics, methodology, population and sample 
size, setting and the country where the study was conducted. These results will be 
discussed in Chapter Four.  Data was entered into Review Manager 5.2 software and 
checked for accuracy. Graphs and tables were created from the results and are presented in 
the next chapter. The excluded articles were tabulated as well as reasons for exclusion 
documented (see Tables 5 and 6). 
 
3.3.6 Data analysis and synthesis 
Data analysis refers to the technique used to reduce information, organise it and provide 
meaning to the retrieved data (Burns & Grove, 201:535). Data synthesis provides an overall 
summary of the findings and it includes the documentation of differences as well as 
consistencies between similar studies (Joubert & Ehrlich, 2008:72). The data can be 
reported narratively and as a meta-analysis. A meta-analysis is described by Grove et al. 
(2013:699) as the pooling of statistical results from several studies into a single quantitative 
analysis. This provides the researcher with the highest level of evidence for an intervention’s 
accuracy study. Meta-analyses are usually used when studies address the same question, 
uses similar population; administer the same intervention and measures similar outcomes 
(Botma et al., 2010:245).  
The study results were presented separately. The statistical software Review Manager 5.2 
was used. The researchers calculated the test performance for predicting acute coronary 
syndrome of each index test compared with MACE as primary outcome. The results were 
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categorised into true positives value (TP), false positives value (FP), true negatives value 
(TN) and false negatives value (FN) for each study. The TP refers to the number of 
individuals who have the disease, whereas the TN refers to the number of individuals who 
do not have the disease. The FP represents those who tested positive for the disease but 
did not actually have it. The FN represents those who tested negative for the disease but 
actually had the disease (Centre for Reviews and Dissemination, 2009). These values were 
taken directly from the source papers, and if this was not possible, values were calculated 
from the data that was provided. The data retrieved was inserted into contingency 2 x 2 
tables. A 2 x 2 table provides a visual illustration of the relationship between the results of 
the index test and the reference standard at a given threshold. The threshold selected for the 
HEART risk score was a score of 0 to 6 = no MACE present, and a score of 7 to 10 = MACE 
present (Backus et al., 2013:4). The GRACE risk score threshold was as follows: 1 to 206,5 
= No MACE present, and a score of 206,5-330 = MACE present (Lee et al., 2011:66); 1 to 
13 = No MACE present and 14 to 20 = MACE present (Lyon et al., 2007:92); 0 to 30 = No 
MACE present, while a score of more than 30 = MACE present respectively (Ramsay et al., 
2007:13). These results were presented as estimates of sensitivity and specificity in a table 
format and illustrated using a forest plot. Sensitivity of a diagnostic test refers to the 
accuracy of the test (Grove et al., 2013:709). Polit and Beck (2012:742) define sensitivity as 
the ability of a screening instrument to correctly identify an individual with a condition. Grove 
et al. (2013:701) on the other hand, define specificity of a diagnostic test as the accuracy of 
a screening test. LoBiondo-Wood and Harber (2010:586) describe it as the measurement of 
how well a test rules out a disease when the disease is really absent. Forest plots in 
diagnostic test accuracy studies report the number of TP, TN, FN and FP for each study, 
and then estimate the sensitivity and specificity with the confidence interval (CI) (Macaskill et 
al., 2010:16). Macaskill et al. (2010:16) further explains that the forest plot is known as a 
coupled forest plot as it contains two graphs, one depicting sensitivity and another 
specificity.  
The results from the forest plot were illustrated in a graph format using the summary receiver 
operating characteristics curve (SROC). The SROC curve represents the performance of a 
diagnostic test (Walter, 2002:1237). Walter describes the SROC curve as a curve that 
illustrates the relationship between true positive rates and the false positive rates across 
different studies. The SROC curve estimates the expected values of sensitivity and 
specificity for a test across many thresholds (Macaskill et al., 2010:18). The SROC curve 
thus illustrates the trade-off between sensitivity and specificity of the diagnostic test due to 
varying diagnostic thresholds (Centre for Reviews and Dissemination, 2009). The SROC 
curve has two axes, the horizontal axis representing the false positive rate (1-specificity) and 
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the vertical axis representing the true positive rate (sensitivity) (Rosman & Korsten, 
2007:77). The SROC is similar to the receiver operating characteristics curve, but each 
plotted point indicates a different study result (Jones & Athanasiou, 2005:18). The SROC 
curve is shaped by the results across studies. Not all the points will lie on the SROC curve, 
because the curve is positioned as close as possible to the overall data set (Jones & 
Athanasiou, 2005:18). There is a diagonal line running through the middle of the SROC 
graph and this line represents a line of no-discrimination (Jones & Athanasiou, 2005:18). 
This implies that any study result plotted on this line shows that the test is uninformative; a 
random guess could just as well be taken to predict whether a patient has the disease or not. 
Jones and Athanasiou (2005:18) explain that this is where sensitivity and specificity is 50%. 
The top left-hand corner is where sensitivity and specificity is 100% and this is known as the 
perfect classification (Zhu, Zeng & Wang, 2005:3). Any study result plotted to the left above 
the no-discrimination line indicates that a test has value and is able to discriminate between 
disease and no-disease (Eng, 2005:910). The closer the plot is to the left-hand border and to 
the top of the border, the more accurate the test will be (Thomas, 2003). Therefore the 
overall accuracy of a test is measured by the closeness of the graph to the left-hand corner. 
The closer the graph is, the higher the sensitivity and specificity of the test (Jones & 
Athanasiou, 2005:18). The closer the plot is to the 45-degree diagonal line the less accurate 
the test will be (Thomas, 2003). Any study result plotted below the no-discrimination line to 
the right indicates that the test has no value and is unable discriminate between disease and 
no disease (Eng, 2005:910). Zhu et al. (2005:4) contend that in order to measure the 
accuracy of a diagnostic test, the researcher must calculate the area under the curve (AUC). 
The larger the AUC and the closer the value approaches 1, the more accurate the test will 
be. An AUC of 0,5 indicates that a test is worthless (Jones & Athanasiou, 2005:18). The 
researcher will not calculate the AUC as part of the data synthesis process. The researcher 
will use a rough guide proposed by Thomas (2003) to estimate and then classify the AUC 
with a traditional academic point system based on the curve of the SROC. The point system 
is as follows: 
 ,90 to 1 = excellent 
 ,80 to ,90 = good 
 ,70 to ,80 = fair 
 ,60 to ,70 = poor 
 ,50 to ,60 = fail 
Thomas (2003) uses a ROC curve diagram (Figure 3.1) to indicate excellent, good, and 
worthless tests plotted on the same graph with the use of the point system. He uses the 
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values above and categorizes them into three main classes. An excellent test ranging 
between 0,8 and 0,9, a good test ranging between 0,7 and 0,8 and a worthless test ranging 
between 0,5 and 0,6. He states that the accuracy of a diagnostic test will depend on how 
well that test is able to identify those with disease and those without the disease. 
 
  Figure 3.1: ROC curve diagram 
 
 
 
 
 
 
 
 
 
3.4  SUMMARY 
In Chapter One, the researcher discussed very briefly the research design and methods 
used. In Chapter Two the researcher provided a discussion on the existing body of 
knowledge regarding risk assessment tools and acute coronary syndrome. A research 
design and research method is of great importance in the planning and implementation of a 
research study. In this chapter the researcher discussed these elements in great depth as 
well as how each was implemented in this study. In Chapter Four, the results of the search 
strategy, critical appraisal, data extraction and data synthesis are described. 
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CHAPTER FOUR: RESULTS 
 
In the previous chapters, the research methods and the background literature relevant to the 
research topic was described. In this chapter, the researcher describes the results of the 
search, the quality assessment and the data synthesis. The results are also summarised in 
tables and graphs in this chapter. 
 
4.1  INTRODUCTION 
Data was collected in the empirical phase of a study must be summarised, analysed and 
interpreted. A researcher discusses the process and the findings in the result section of a 
study. This phase is known as the interpretative phase (Brink et al., 2012:56). The results of 
the data analysis set the stage for interpretation, discussion and limitations section of a study 
(LoBiondo-Wood et al., 2010:336). The researcher will discuss the findings of the sampling 
procedure (identified relevant studies for inclusion), the findings of the quality assessment 
(examining for completeness and accuracy of included studies) and then summarise the 
evidence from data that was extracted. 
 
4.2  SEARCH RESULTS 
The search was conducted with the aim of locating and including all studies relevant to the 
research question. The first step of the search was to perform a broad search, thereby 
ensuring that all possible studies were included. Then filtering of studies was done to ensure 
all included studies were relevant. 
 
4.2.1 Sources  
The researcher ensured that the search was unbiased by including multiple sources, thereby 
identifying all potentially relevant studies as illustrated in Table 4.1 below. 
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Table 4.1: Sources used in search strategy 
Electronic database Type of literature included 
International 1.Cochrane Library 
2. MEDLINE 
3. Embase 
4. CINAHL 
Systematic reviews of studies 
Journal articles 
Journal articles 
Journal articles 
National 1. SUNScholar Theses and dissertations 
Other studies 
Manual  Grey literature searched such as 
conference proceedings, unpublished 
research theses 
 Manual search used to obtain articles from 
the internet identified from reference lists 
 
Four electronic databases were searched using search strings (Cochrane Library, 
MEDLINE, Embase and CINAHL) to identify potential journal articles. Databases were 
searched for articles from inception to 2014 and there were no language restrictions on the 
search. SUNScholar was also searched for relevant theses or dissertations on the topic. A 
manual search was conducted to search for grey literature such as conference proceedings 
(American Heart Association, British cardiovascular society, European Society of Cardiology, 
American College of Cardiology and American College of Chest Physicians) and other 
relevant articles identified from reference lists using the internet. 
 
4.2.2 Search terms 
A combination of keywords was used to search for literature. The following keyword 
combinations were used as displayed in Tables 4.2 and 4.3. 
 
Table 4.2: Search strings for Cochrane Library, MEDLINE & CINAHL 
Database Search string 
Cochrane Library 
 
MEDLINE 
 
CINAHL 
 
 
A: “ACS AND Risk assessment AND GRACE OR HEART OR
      HEARTS3” 
 
B: “ACS AND Risk prediction AND GRACE OR HEART OR  
     HEARTS3” 
 
C: “ACS AND Risk stratification AND GRACE OR HEART OR  
     HEARTS3” 
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D: “NSTEMI OR STEMI OR Unstable angina pectoris AND Risk
      assessment AND   GRACE OR HEART OR HEARTS3” 
 
E: “NSTEMI OR STEMI OR Unstable angina  pectoris AND Risk  
     prediction AND GRACE OR HEART OR HEARTS3” 
 
F: “NSTEMI OR STEMI OR Unstable angina pectoris AND Risk  
     stratification AND  GRACE OR HEART OR HEARTS3” 
 
G: “Chest pain AND Risk assessment AND  GRACE OR HEART 
      OR HEARTS3” 
 
H: “Chest pain AND Risk prediction AND GRACE OR HEART  
      OR HEARTS3” 
 
I:  “Chest pain AND Risk stratification AND GRACE OR HEART 
      OR HEARTS3” 
 
 
Table 4.3: Search strings for Embase 
Embase A 1: “ACS AND Risk assessment AND GRACE”  
A 2: “ACS AND Risk assessment AND HEART OR HEARTS3” 
 
B &C 1: “ACS AND Risk prediction OR Risk stratification AND  
              GRACE”  
B & C 2: “ACS AND Risk prediction OR Risk stratification AND 
              HEART OR HEARTS3” 
 
D 1: “NSTEMI OR STEMI OR Unstable angina pectoris AND Risk 
         assessment AND   GRACE”  
D 2: “NSTEMI OR STEMI OR Unstable angina pectoris AND Risk  
         assessment AND   HEART OR HEARTS3” 
 
E 1: “NSTEMI OR STEMI OR Unstable angina pectoris AND Risk 
         prediction AND   GRACE”  
E 2: “NSTEMI OR STEMI OR Unstable angina pectoris AND Risk 
         prediction AND   HEART OR HEARTS3” 
 
F 1: “NSTEMI OR STEMI OR Unstable angina pectoris AND Risk 
        stratification AND   GRACE”  
F 2: “NSTEMI OR STEMI OR Unstable angina pectoris AND Risk  
        stratification AND   HEART OR HEARTS3” 
 
G 1: “Chest pain AND Risk assessment AND GRACE”  
G 2: “Chest pain AND Risk assessment AND HEART OR  
         HEARTS3” 
 
H 1: “Chest pain AND Risk prediction AND GRACE”  
H 2: “Chest pain AND Risk prediction AND HEART OR  
         HEARTS3” 
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I 1: “Chest pain AND Risk stratification AND GRACE” 
I 2: “Chest pain AND Risk stratification AND HEART OR  
        HEARTS3” 
 
To ensure that relevant data was not missed, the search strings were searched in the 
categories of All or Title or Abstract. There was a lack of relevant results from Embase 
database when the full combination of search string was used. The researcher therefore 
selected keyword combinations to obtain relevant results as displayed in Table 4.3. 
 
4.2.3 Documentation of search 
The search was documented and Table 4.4 provides a summary of the results of the search. 
 
Table 4.4: Summary of search  
Summary of search Database Search results 
 
Electronic database: 
International 
 
1. Cochrane Library  
2. MEDLINE 
3. Embase 
4. CINAHL 
 
0 
146 
52 
71 
National 1. SUNScholar 0 
Internet & references  11 
Total:  280 
 
The search yielded a total of 280 articles from the different search sources. In the initial 
search using the search strings in the different databases, titles and abstracts of articles 
were examined and a total of 269 articles were identified.  A total of 11 additional articles 
were identified from reference list of articles. There were 117 duplicate articles from various 
database sources and they were excluded, leaving 163 abstracts to be extracted and 
reviewed for possibility of inclusion.  
From the 163, a further 126 articles were excluded as the abstracts revealed studies not to 
meet the inclusion criteria, and five of the 126 articles were unobtainable due to various 
reasons (Table 4.5). A total of 37 articles were selected for review of full text articles. The 
obtained full text articles were read by the two reviewers independently and a decision was 
made on whether to include articles for critical appraisal as based on the review question. A 
total of 13 full text articles did not meet the inclusion criteria and were excluded (Table 4.5). 
A total of 24 articles remained for critical appraisal. A total of 19 articles were excluded after 
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critical appraisal, for various reasons (Table 4.6). A total of five articles remained for data 
extraction. The results of electronic database and hand searching are outlined in Figure 4.2 
below.  
 
Figure 4.2: Flow of studies identified in literature search for systematic review 
 
 
Table 4.5: Excluded full text articles   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through database 
searched based on titles  
(n = 269)
Additional records identified through 
other sources  
(n = 11) 
              Records after duplicates removed 
                                      (n = 117) 
Records retrieved and abstracts 
 (n = 163)  
Records excluded  
(n = 126) 
Full text articles assessed for 
eligibility  
 (n = 37) 
Full text articles excluded 
 (n = 13)   
See Table 4.5 for reasons 
Studies for critical appraisal 
 (n = 24) 
Studies for data extraction 
(n = 5) 
Studies excluded 
 (n = 10)  Not assess ACS 
spectrum 
(n = 1) Summary 
(n = 8) Outcomes not MACE 
See Table 4.6 for reasons 
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Table 4.5: Excluded full text articles 
Article Identification Reason for exclusion 
1.   Graham et al., 2014 Not available for free  
2.   Graham et al., 2014 Not available for free  
3.   Backus et al., 2009      Powerpoint summary of articles done on HEART risk 
score 
4.   Barba et al., 2013 Only in Italian, no English version 
5.   Martin et al., 2013 No English version 
6.   Abelin et al., 2013 Only assesses one spectrum: STEMI 
7.   Barbosa et al., 2012 Only assesses one spectrum: NSTE-ACS 
8.   D'Ascenzo  et al., 2012 Systematic review 
9.   Fesmire  et al., 2012 Only assesses one spectrum: NSTE-ACS 
10. Filipiak et al.,  2011  Validate another tool by comparing to GRACE 
11. Fox et al., 2010 SUMMARY
12. Gale et al.,  2008 Validate another tool by comparing to GRACE 
13. Gonc¸alves et al., 2005 Only assesses one spectrum: NSTE-ACS 
14. Khalill et al., 2009 Only assesses one spectrum: NSTE-ACS 
15. Scruth et al.,  2013 Only assesses one spectrum: STEMI 
16. Backus et al., 2008 Only assesses one spectrum: NSTE-ACS 
17. GRACE Investigators, 2001 Not a diagnostic study 
18. Yan et al.,  2007 Only assesses one spectrum: NSTE-ACS 
 
4.3  QUALITY ASSESSMENT 
A total of 24 studies remained for critical appraisal. Critical appraisal is the last step of the 
sampling procedure where the researcher evaluates the methodological quality of selected 
articles. The QUADAS 2 tool (see Appendix B) was found to be applicable for critical 
appraisal and is recommended by the Cochrane group for systematic reviews of diagnostic 
test accuracy studies.  
The internal validity of the study was ensured because the critical appraisal tool fitted the 
design. The QUADAS 2 tool is a structured and objective instrument used to assess quality 
of articles, reducing the risk of researcher’s bias. Twenty-four full text articles were critically 
appraised using the QUADAS 2 tool. Of the 24, a total of 19 articles were excluded for 
various reasons as stated above (Table 4.6).   
 
Table 4.6: Excluded studies after critical appraisal  
Article Identification Reason for exclusion 
1.   Conti et al.,  2012 Excludes STEMI & NSTEMI 
2.   Correia et al,. 2009 Only assesses one spectrum: NSTE-ACS 
3.   Cullena et al.,  2013 Excludes STEMI 
4.   Goodacre et al., 2012 Excludes STEMI 
5.   Halpern et al., 2013 Excludes STEMI 
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6.   Mahler et al., 2011 Excludes STEMI 
7.   Marcoon et al. 2013 Excludes STEMI 
8.   Melki et al., 2013 Excludes STEMI 
9.   Poldervaart et al., 2013 Excludes STEMI 
10. Six et al., 2013 Excludes STEMI 
11. Aragam et al., 2009 Outcome: Mortality Not MACE 
12. Backus et al.,  2013 Summary 
13. Bajaj et al.,  2012 Outcome: Death and Re-MI, not MACE 
14. Elbarouni et al., 2009 Outcome: In hospital mortality not MACE 
15. Meune et al., 2011 Outcome: Death & AMI, not MACE 
16. Mahmoud 2009 Outcome: Mortality, not MACE 
17. Prabhudesai et al.,  2012 Outcome: Mortality & MI, not MACE 
18. Stracke et al.,  2010 Outcome: Mortality not MACE 
19. Soderholm et al., 2011 Outcome: Low-risk complications, not MACE 
 
Five articles were included in the review. The methodological quality of the included studies 
is illustrated in Table 4.7.  
Table 4.7: QUADAS 2 risk of bias 
Study  RISK OF BIAS  APPLICABILITY CONCERNS 
PATIENT 
SELECTION 
INDEX 
TEST 
 
REFERENCE 
STANDARD 
 
FLOW 
AND 
TIMING 
PATIENT 
SELECTION 
 
INDEX 
TEST 
REFERENCE 
STANDARD 
Backus 
2010 
          
Backus 
2013 
  ?        
Lee 2011            
Lyon 2007  ?          
Ramsay 
2007 
          
 Low Risk   High Risk    ? Unclear Risk  
The two reviewers independently assessed the 24 articles included for risk of bias. The risk 
of bias for the included studies varied.  One article of the final five studies had incomplete 
data under the patient selection Domain 1 (Lyon 2007), where 21 patients were missing from 
the initial sample, and the reason for this was not stipulated in the study. The remaining four 
studies had low risk of bias for Domain 1. Two of the studies had been identified as 
potentially biased due to poor reporting on the index test (Domain 2). In the Backus et al. 
2013 article, the threshold was not pre-specified but reference was made to a previous study 
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performed. Thus the domain was marked as unclear. The other study (Lyon et al. 2007) had 
been identified as high risk of bias in Domain 2 (the index test) as there was no pre-specified 
threshold given. All articles had low risk of bias in Domain 3 reference standards and 
Domain 4 (flow and timing). All five articles were applicable in all four domains to this study. 
A total of five articles of good methodology quality remained for data extraction.                                             
4.4 DATA EXTRACTION 
The researchers independently extracted data from eligible studies. Data was extracted from 
the final five studies using an adapted standard data extraction form from the Cochrane 
website (see Appendix C). The data extraction characteristics of these studies are displayed 
in Table 4.8.  
Table 4.8: Characteristics of articles for inclusion  
Study 
Identificatio
n 
Methods Size Intervention Outcome 
1.  Backus et 
al.,  2010 
Retrospective 
multicentre 
analysis – 
cohort study 
n=880 Duration:  
1 January – 31 March 
2006 
 
Index-test: HEART 
MACE in 6 weeks 
(AMI, PCI, CABG & death) 
 
Reference standard: 
-PCI: hospital charts (therapeutic 
catheter intervention in coronary 
arteries) 
-CABG: hospital charts 
(cardiac surgery on coronary arteries) 
-AMI (typical chest pain, ECG 
changes, rise troponin levels & 
creatinine phosphokinase 
-Death 
2.  Backus et 
al., 2013 
Prospective 
study – cohort 
study 
n=2388 Duration:                    
October 2008 – November 
2009 
 
Index test: 
HEART 
MACE in 6 weeks 
(AMI, PCI, CABG, death) 
 
Reference standard: 
- PCI: patient records 
(therapeutic catheter intervention in 
coronary arteries) 
-CABG: hospital charts 
(cardiac surgery on coronary arteries) 
- AMI (rise and fall troponin level 
above 99 percentile with evidence of 
myocardial ischemia, distinction made 
STEMI/NSTEMI see article) 
-Death 
 
3.  Lee et al., 
2011 
Secondary 
analysis 
prospective 
cohort study 
n=4743 Duration: Not specified 
 
Index test: 
GRACE 
MACE in 30 days 
(AMI, death, revascularisation (PCI & 
CABG) 
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Reference standard: 
- Death: record review, family 
member or social security death index 
- Revascularisation: record review, 
PCI or CABG 
- AMI ( as per European society of 
cardiology & American college of 
cardiology guidelines: rise or fall 
troponin level above 99 percentile of 
upper ref limit with one of flw: 
symptoms of ischemia; new 
significant ST or T changes or new 
LBBB; Pathological Q wave on ECG) 
4.  Lyon et 
al., 2007 
Retrospective 
descriptive 
study – cohort 
study 
n=734 Duration: 2-month period  
 
Index test: 
GRACE 
MACE in 30 days 
(STEMI, positive troponin ACS, PCI, 
death) 
 
Reference standard: 
-Mortality: hospital recorded, 
telephone calls 
- PCI 
- ST elevation MI or Troponin positive 
ACS 
5.  Ramsay 
et al., 2007 
Prospective 
observational 
study – cohort 
study 
n=347 Duration: 
November 2005 – 
February 2006 
 
Index test: 
GRACE 
MACE in hospital and at 3 months 
(mortality, MI, revascularisation) 
 
Reference standard: 
-Mortality: electronic patient 
database 
- Revascularisation: electronic 
patient database 
- MI: (ST deviation, troponin 
elevation) 
 
Data that was extracted from the five included articles was the study design used, participant 
characteristics (setting, size, age, signs and symptoms), intervention (duration of study, 
index test used) and primary outcomes, including the reference standard used. Of the five 
articles, two assessed the HEART risk assessment tool and its ability to diagnose patients 
with acute coronary syndrome. The remaining three articles assessed the GRACE risk 
assessment tool and also the ability to confirm the presence of acute coronary syndrome. 
The HEART studies used different study designs – one a retrospective design and the other 
a prospective design. The research designs used by the GRACE studies were a 
retrospective study (one article) and a prospective design (the other two articles). All five 
articles identified chest pain as the main sign and symptom with which a patient presented. 
The outcomes of the two HEART studies assessed the occurrence of major adverse cardiac 
events (MACE) within six weeks. MACE was used in all the studies as the outcome as it 
describes adverse events of acute coronary syndrome, and thus serves as indirect proof of 
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diagnosis of acute coronary syndrome (Backus, 2010:164). The main four adverse events 
are percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG), acute 
myocardial infarction (AMI) – which is described as chest pain with ECG changes and/or 
elevated troponin levels – and finally, death. The three GRACE studies outcomes were also 
MACE. Two articles assessed the outcome of MACE within a 30-day period follow up. The 
other article assessed the outcome of MACE occurring while patient was in hospital and 
occurring at three months follow-up period. The outcomes were similarly described as for the 
HEART studies but PCI and CABG were classified as revascularisation. Data extracted 
included the sample size and the main findings, as illustrated in Table 4.9. 
Table 4.9: Summary of study 
Article 
Identification 
 
Participants 
 
Outcomes 
measured 
Summary of main 
findings 
1. Backus et al.,  
    2010  
 
Setting: Four separate 
hospitals in the 
Netherlands. Three sites were 
community-based hospitals: 
Emergency department 
 
Age: No restrictions 
(Mean age of participants 61 
with standard deviation of 
15,7) 
 
Signs & symptoms: Chest 
pain 
 
- MACE in 6 weeks 
(AMI, PCI, CABG & 
death) 
 - 58/880had MACE in 
6 weeks. 
 
- HEART score has a 
great discriminatory 
ability. 
2. Backus et al., 
    2013  
 
Setting: Ten hospitals in the 
Netherlands: Emergency 
department 
 
Age: No restrictions 
(Mean age was 60 with 
standard deviation of 15,4) 
 
Signs & symptoms: 
Chest pain 
- MACE in 6 weeks 
(AMI, PCI, CABG, 
death) 
-407/2388 had MACE 
in 6 weeks.  
 
-HEART score is a 
reliable predictor of 
MACE. 
3. Lee et al., 2011  
 
Setting: Hospital of the 
University of Pennsylvania: 
Emergency department 
 
Age: >30 years 
Signs & symptoms: 
Chest pain or equivalent that is 
concerning for ACS 
 
- MACE in 30 days 
(AMI, death, 
revascularisation 
(PCI & CABG) 
- 319/4743 had MACE 
in 30 days. 
 
- GRACE identified 
participants for MACE 
correctly, there was 
increasing MACE with 
increased risk score. 
4. Lyon et al., 
    2007  
Setting: Edinburgh Royal 
Infirmary, 
- MACE in 30 days 
(STEMI, positive 
- 123/760 had one 
MACE at 30 days. 
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 Scotland: Emergency 
department 
 
Age: >20 years 
 
Signs &Symptoms: 
Chest pain 
 
troponin ACS, PCI, 
death) 
  
- 28/760 had multiple 
MACE at 30 days. 
 
-GRACE has potential 
to risk stratify patients 
with chest pain. 
 
5. Ramsay et al., 
    2007  
 
Setting: - Royal 
Infirmary of Edinburgh: 
accident and emergency 
department, the combined 
assessment area, coronary 
care unit or direct to a 
cardiology ward 
 
Age:> 18 years 
 
Signs & symptoms: 
Chest pain 
- MACE in hospital 
and at 3 months 
(mortality, MI, 
revascularisation 
-140/347 was 
diagnosed with ACS on 
discharge & 8/347 had 
MACE. 
 
-24/347 had MACE at 3 
months 
 
-GRACE found to be 
predictive of these 
MACE 
 
In the study of the HEART risk score, the sample size was n=880; 158 of this sample had 
MACE within 6 weeks. It was found that the HEART score had great discriminative ability. 
The other study on the HEART risk score had a sample size of n=2388 of which 407 had 
MACE within 6 weeks. It was found that the HEART score was a reliable predictor of MACE. 
The specifics of the sample size with MACE versus those without MACE, and in which risk 
score group the events occurred, have been illustrated in Table 4.10. 
 
Table 4.10: Summary of findings for HEART risk score 
HEART Studies Score levels No. patients 
with MACE 
No. patients 
without 
MACE 
Backus et al., 
2010 
Low 0-3 3 300 
n=880 Medium 4-6 48 365 
 High 7-10 107 57 
Total:  158 722
 
HEART Studies Score levels No. patients 
with MACE 
No. patients 
without 
MACE 
Backus et al., 
2013 
Low 0-3 15 855 
n=2388 Medium 4-6 183 918 
 High 7-10 209 208 
Total:  407 1981 
 
Stellenbosch University  https://scholar.sun.ac.za
53 
 
In the study of GRACE risk score the sample size was n=4743, of which 319 had MACE in 
30 days; the GRACE score was found to have correctly identified patients for MACE. The 
next study had a sample size of 760 of which 123 had MACE and 28 had multiple MACE. 
The originators of the GRACE score stated that the GRACE risk score had the  potential to 
accurately risk-stratify patients. The last study of the GRACE risk score had a sample size of 
n=347. Of these, 140 had a discharge diagnosis of ACS, 8 had MACE in hospital and 24 had 
MACE at 3 months after hospitalisation. The GRACE score was found to be predictive of 
these outcomes. The specifics regarding the amount of sample size that had MACE versus 
those without MACE and in what risk score group the events occurred has been illustrated in 
Table 4.11. 
 
Table 4.11: Summary of findings for GRACE risk score 
GRACE studies Score levels No. patients 
with MACE 
No. patients 
without 
MACE
Lee et al., 2011 1-41.25 1 214 
n=4743 41.25-82.5 59 2252 
 82.5-123.75 134 1411 
 123.75-165 83 449 
 165-206.25 33 81 
 206.25-247.5 8 16 
 247.5-288.75 1 1 
 288.75-330 0 0 
Total:  319 4424 
 
GRACE studies Score levels No. patients 
with MACE 
No. patients 
without 
MACE 
Lyon et al., 2006 1-5 12 287 
n=734 6-9 37 223 
 10-13 49 80 
 14-16 15 17 
 17-20 10 4 
Total:  123 611 
 
GRACE studies Score levels No. patients 
with MACE 
No. patients 
without 
MACE 
Ramsay et al., 2007 Low  <15 1 136 
n=347 
(140 were ACS) 
Medium   
16-30 
4 115 
 High  >30 19 72
Total:  24 323 
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The number of patients who had MACE in the specific period as described by each study are 
further classified into secondary outcomes namely PCI, CABG, AMI and death and these are 
illustrated in Tables 4.12 and 4.13. 
Table 4.12: MACE findings of HEART risk score 
Study identification No. of patients with MACE Secondary outcomes  
(AMI, PCI, CABG, death) 
1. Backus et al., 2010 
 
n=158 AMI: 92 
PCI: 82 
CABG: 36 
PCI & CABG: 1 
Death: 13 
2. Backus et al., 2013 n= 407 AMI:155 
PCI: 251 
CABG: 67 
Death: 13 
 
 
Table 4.13: MACE findings of GRACE risk score 
Study identification No. of patients with 
MACE 
 Secondary outcomes  
(AMI, PCI, CABG, death) 
3. Lee et al., 2011 n= 319 AMI: 163 in hospital 
      : 172 at 30 days 
Revascularisation: 155 in hospital 
                             : 175 at 30 days 
Death: 28 in hospital 
           : 59 at 30 days 
 
4. Lyon et al., 2007 n= 123 AMI (STEMI & Troponin positive ACS & 
readmit with AMI): 40; 65; 1 
Revascularisation: 29 
Death: 16 
5. Ramsay et al., 
2007 
n= 8 in hospital 
n=24 in 3 months 
AMI: 3 in hospital 
      : 7 at 3 months 
Revascularisation: 0 in hospital 
                             : 1 at 3 months 
Death:  5 in hospital 
          : 16 at 3 months 
In addition to MACE findings: Re-
admission for ischemic chest pain 17 
 
4.5 DATA SYNTHESIS 
Data synthesis was performed using Review Manager 5.2 software. Study results were 
collected from the five inclusion articles. The results of each study were entered into a 2x2 
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contingency table (see Tables 4.14 to 4.18). A 2x2 contingency table categorises study 
subjects for several purposes. The variables of each study are assigned to a class 
(TP,TN,FP,FN) and then the information in the table is used to measure associations 
between them, for example to determine the sensitivity and specificity of a diagnostic tool 
(University of Michigan, 2010). 
 
Table 4.14: Backus et al., 2010 2x2 contingency table 
REFERENCE Standard  MACE in 6 weeks Total: 
Positive MACE Negative No MACE 
 
 
Table 4.15: Backus et al., 2013 2x2 contingency table 
REFERENCE Standard  MACE in 6 weeks Total: 
Positive MACE Negative No MACE 
 
 
Table 4.16: Lee et al., 2011 2x2 contingency table 
REFERENCE Standard  MACE in 30 days Total: 
Positive MACE Negative No MACE 
 
INDEX Test 
HEART  
Positive 
7-10 risk score group 
              TP 
107  
               FP 
57  
 
164 
Negative 
0-6 risk score group 
              FN 
51  
               TN 
665  
 
716 
Total: 158 722 n=880 
INDEX Test 
HEART  
Positive 
7-10 risk score group 
              TP 
209 
               FP 
208  
 
417 
Negative 
0-6 risk score group 
              FN 
198 
               TN 
1773  
 
1971 
Total: 407 1981 n=2388 
INDEX Test 
GRACE 
Positive 
206,25-330 
              TP 
9 
               FP 
17 
 
26 
Negative 
0-206,25 
              FN 
310 
               TN 
4407 
 
4717 
Total: 319 4424 n=4743 
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Table 4.17: Lyon et al., 2007 2x2 contingency table 
REFERENCE Standard  MACE in 30 days Total: 
Positive MACE Negative No MACE 
 
 
Table 4.18: Ramsay et al., 2007 2x2 contingency table 
REFERENCE Standard  MACE in 3 months Total: 
Positive MACE Negative No MACE 
 
The data from the 2x2 contingency tables was grouped together for the HEART risk score to 
create a coupled forest plot depicting sensitivity and specificity (see Figure 4.3).  
 
Figure 4.3: Forest plot for HEART risk score 
 
 
INDEX Test 
GRACE 
Positive 
14-20 
              TP 
25 
               FP 
21 
 
46 
Negative 
1-13 
              FN 
98 
               TN 
590 
 
688 
Total: 123 611 n=734 
INDEX Test 
GRACE 
Positive 
> 30 
              TP 
19 
               FP 
72 
 
91 
Negative 
0-30 
              FN 
5 
               TN 
251 
 
256 
Total: 24 323 n=347 
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Two studies on the HEART risk score provided data from 3268 individuals. Values of 
sensitivity were low in both studies whereas the specificity was high. The sensitivity of the 
HEART risk score varied from 0,51 (95% CI 0,46 to 0,56) (Backus 2013)) to 0,68 (95% CI 
0,60 to 0,75) (Backus 2010)) respectively. The specificity varied from 0,90 (95% CI 0,88 to 
0,91) (Backus 2013)) to 0,92 (95% CI 0,90 to 0,94) (Backus 2010)) respectively.  
The data from the forest plot was used to create an SROC curve for the HEART risk score 
as illustrated in Figure 4.4. The SROC curve has two axes, the horizontal axis representing 
the false positive rate (1-specificity) and the vertical axis representing the true positive rate 
(sensitivity). There is a straight line running through the middle of the graph. This line 
represents the area of no-discrimination. The test is thus uninformative if plotted anywhere 
on this line.  
Figure 4.4 follows on page 58. 
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Figure 4.4: SROC curve for HEART risk score 
 
The sensitivity and specificity of the two HEART studies has been plotted with a clear circle 
in the ROC space. The SROC curve is placed as close as possible to both data sets. The 
SROC curve lies on the left side of the diagonal line, signifying that the HEART risk score 
has value in its prediction ability of acute coronary syndrome. This means that the tool is 
better than a random guess for predicting whether a patient has the disease or not. The AUC 
is estimated to be between 0.7 and 0.8 when using the traditional academic point system 
which indicates that the tool has a fair ability to accurately predict the presences of acute 
coronary syndrome in adults. The HEART risk score has a 70% to 80% probability of 
correctly classifying a patient as diseased or not. 
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The data from the 2x2 contingency tables was grouped together for the GRACE risk score to 
create a coupled forest plot depicting sensitivity and specificity (see Figure 4.5). 
 
Figure 4.5: Forest plot for GRACE risk score 
 
 
Three studies on the GRACE risk score provided data from 5824 individuals. Values of 
sensitivity varied between low and high whereas the specificity in all three studies was high. 
The sensitivity of the GRACE risk score varied, in the first study the sensitivity was 0,03 
(95% CI 0,01 to 0,05) (Lee 2011)). The sensitivity in the second study was 0,20 (95% CI 
0,14 to 0,29) (Lyon 2006)) and in the third study it was 0,79 (95% CI 0,58 to 0,93) (Ramsay 
2007)).  The specificity varied among the three studies. In the first study the specificity was 
1,00 (95% CI 0,99 to 1,00) (Lee 2011). In the second study the specificity was 0,97 (95% CI 
0,95 to 0,98) (Lyon 2006)) and in the third study the specificity was 0,78 (95% CI 0,73 to 
0,82) (Ramsay 2007)). 
The data from the forest plot was used to create an SROC curve for the GRACE risk score 
as illustrated in Figure 4.8 on page 60. 
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Figure 4.6: SROC curve for GRACE risk score 
 
The sensitivity and specificity of the three GRACE studies has been plotted with a clear 
circle in the ROC space. The SROC curve is placed as close as possible to all three data 
sets. The SROC curve lies on the left side of the diagonal line, signifying that the GRACE 
risks score has value in its prediction ability of acute coronary syndrome. This means that 
the tool is better than a random guess for predicting whether a patient has the disease or 
not. The AUC is estimated to be between 0.8 and 0.9 when using the traditional academic 
point system, which indicates that the tool has a good ability to accurately predict the 
presence of acute coronary syndrome in adults. The GRACE risks score has an 80% to 90% 
probability of correctly classifying a patient as diseased or not. 
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The two forest plots shown in Figure 4.7 were combined with the two SROC curves into one 
ROC space (Figure 4.8), to allow the researcher to make a comparison between the HEART 
and GRACE risk scores. The purpose was to determine which of the two tools has a greater 
ability to accurately predict the presence of acute coronary syndrome in adults. 
 
Figure 4.7: Comparison of GRACE and HEART forest plots 
 
Figure 4.8 follows on page 61. 
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Figure 4.8: Comparison of GRACE and HEART SROC 
 
Each risk tool was allocated its own shape and colour in the ROC space to make 
differentiation between the two tools easier. The HEART risk score is illustrated with a clear 
black round circle and a black curve, whereas the GRACE risk score is illustrated with a red 
diamond shape and a red curve. As mentioned above, both the SROC curves are situated 
on the left side of the diagonal line, which indicates that both tools are valuable. The AUC for 
both tools is greater than 0,5 which indicates that neither of the two risk tools is worthless. 
When assessing the AUC according to the traditional academic point system, it is evident 
that the GRACE risk score range (0,8 to 0,9) is higher than the HEART risk score range (0,7 
to 0,8). This shows that the GRACE risk score has a probability of 80% to 90% of correctly 
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classifying a random positive-negative case pair. The HEART risk score has a probability of 
70% to 80% of correctly classifying a random positive-negative case pair. 
 
4.6  SUMMARY 
In this chapter, the researcher described the results of the search and the quality 
assessment that was performed which represented the sampling procedure of the thesis. 
The researcher also described the findings of the data extraction and synthesis process. In 
the next chapter, the researcher discusses the results and draws conclusions from the 
findings. A discussion of the limitations of the study will also be presented and the 
researcher will then make recommendations for research and nursing practice. 
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CHAPTER FIVE: DISCUSSION, CONCLUSIONS AND 
RECOMMENDATIONS 
 
In the previous chapter, the results of the search, quality assessment, data analysis and 
synthesis were described. In this chapter the researcher discusses the results, draws 
conclusions and makes recommendations.  
 
5.1  INTRODUCTION  
The researcher discusses each objective described in the first chapter and discusses 
whether these objectives were attained. Limitations that were encountered are described 
and the researcher will conclude by posing recommendations for future research. 
 
5.2  DISCUSSION 
The following research question was stated in Chapter One: What is the prediction ability of 
risk assessment tools in predicting acute coronary syndrome in adults? 
The aim of the study was to systematically appraise evidence on the accuracy of risk 
prediction tools for acute coronary syndrome in adults. The study therefore investigated 
whether the HEART and GRACE risk assessment tools could accurately predict the 
presence of acute coronary syndrome in adults. To be able to answer the research question 
the researcher created objectives to guide the study. The objectives were as follows: 
 To estimate the accuracy of GRACE and HEART in predicting acute coronary 
syndrome in adults. 
 To compare the accuracy of the two tools in risk prediction of acute coronary 
syndrome in adults. 
 To propose recommendations for a potential risk assessment tool for South Africa. 
 
WHO (2012) state that there is a need to increase government investment in prevention and 
early detection of CVD as the death rates for this disease are increasing.  
Acute coronary syndrome is diagnosed with the use of a physical examination, history taking 
and reference standards (ECG and cardiac markers) (Dalby, 2001:88). This author explains 
that there are limitations and drawbacks with ECG and cardiac markers and these can lead 
to a false negative result, resulting in a missed diagnosis and subsequent advance disease 
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and death.  Ramsay et al., (206:12) advise that one cannot rely on ECG and clinical 
symptoms only as they have low diagnostic accuracy. They therefore suggest adding 
troponin I to aid the diagnosis process. Symptoms experienced by patients may not always 
indicate myocardial ischemia, and elevated troponin levels may not always indicate that the 
disease is present as both are not specific or isolated to acute coronary syndrome only. In 
addition, Troponin I and T take at least six to twelve hours before increasing, thus still 
leaving room for error when diagnosing a patient (Kumar & Cannon, 2009:921).  
A study performed by Yan et al.  (2007:1074) compared risk categorisation by physicians to 
risk categorisation by risk scores. The high risk group risk stratified by the physician were 
three times more likely to die due to acute coronary syndrome whereas the high-risk group 
stratified by the risk score were five times more likely to die. The results proved that risk 
scores had more accurately risk-stratified a patient than the treating physician. Yan et al. 
(2007:1076) emphasise that risk scores are clinical tools and should not replace clinical 
judgement, the reason being that the tool will not be able to correctly risk-stratify a patient 
with a more complex history. Another study was performed by Yan et al. (2009:379) to 
examine the risk assessment done by physicians and compare it to an objective risk score 
evaluation. The study proved that certain patients risk-stratified by a physician as low risk 
had actually been incorrectly categorised. When compared to the risk stratification of the risk 
score, the risk score correctly stratified these same patients as intermediate or high risk 
patients. Yan et al. (2009:379) concluded that risk scores were found to be superior to 
physician risk assessment and that a risk score was a necessity for accurate and 
comprehensive diagnoses. Yan et al. (2009:376) once again explained that risk score was 
not to replace clinical judgement but rather should form part of clinical judgement.  
Bajaj et al. (2013:202) conducted a similar study to compare physicians’ initial diagnostic 
impression – of possible acute coronary syndrome to definite acute coronary syndrome – 
with the GRACE risk scoring. The study results proved that individuals in the possible group 
had a greater rate of having myocardial infarction than those in the definite group. This result 
compared to the GRACE risk scoring showed that individuals in the possible group had 
higher GRACE risk scores than those in the definite group as stratified by the physician. The 
conclusion drawn was that the GRACE tool provided a more accurate risk assessment than 
the physician not using the GRACE risk assessment tool.  
In total, only five studies describing these two tools, that fulfilled the criteria for a test of 
screening intervention, were identified. The overall methodological quality of the five studies 
was variable. One of the five studies on the HEART risk assessment tool (Backus et al. 
2013) had an overall judgement of unclear risk of bias because the index test threshold was 
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not pre-specified but reference was made to a previous study done. Another study on the 
GRACE risk assessment tool (Lyon et al. 2007) had an overall judgement of high risk of bias 
because details of 21 patients from the initial sample size were missing from the initial 
sample size and the authors did not document this. The other reason for the high risk of bias 
was that no threshold for the index test was pre-specified. The methodological quality of the 
other three studies (Backus et al. 2010; Lee et al. 2011; Ramsay et al. 2007) had an overall 
low risk of bias. There were overall low concerns regarding the applicability of the five 
studies. Two of the five studies would potentially not be replicable due to poor 
methodological reporting. The other three studies would be replicable as they had good 
methodological reporting. 
Three of the five studies used a prospective research method and two of the studies used a 
retrospective research method. All five studies were cohort studies. In total 9 092 individuals 
were included in the study. The HEART studies included a total of 3 268 individuals and the 
GRACE studies included a total of 5 824 individuals. The main outcome assessed by all five 
studies was MACE within six weeks up to three months. MACE refers to major adverse 
cardiac events occurring due to acute coronary syndrome being present, which therefore 
serves as indirect proof of the prescience of the disease (Backus et al., 2010:164). The four 
major cardiac events of interest for this review were PCI, AMI, CABG and death.  
In total, the two HEART studies identified 565 individuals with MACE; while a total of 2 703 
individuals were identified without MACE. The two studies on the HEART risk assessment 
tool concluded that the HEART risk score had great discriminatory power and was found to 
be a reliable predictor of MACE. The three studies on the GRACE risk score identified a total 
of 466 individuals with MACE and 5 358 were identified without MACE. The three studies on 
the GRACE risk assessment concluded that the GRACE risk score was able to correctly 
identify a patient with MACE; therefore the GRACE risk score was found to be predictive of 
MACE (Lyon et al., 2007; Lee et al., 2011; Ramsay et al., 2007). 
The results of the five studies were reported separately. A coupled forest plot was used to 
illustrate the sensitivity and specificity of each tool. The HEART risk assessment tool proved 
to have a low sensitivity, in that it was only able to accurately predict the prescience of acute 
coronary syndrome in 51% to 68% of patients admitted to the emergency department with 
chest pain. The HEART risk assessment tool, on the other hand, had a high specificity, 
indicating the ability of the tool to accurately predict an adult without acute coronary 
syndrome in 90% to 92% of cases. This confirmed the findings from the two HEART studies 
(Backus et al., 2010; Backus et al., 2013) which showed that the tool was able to correctly 
identify 565 patients with MACE and able to correctly identify 2 703 patients without MACE. 
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The GRACE risk assessment tool also had a low sensitivity, only being able to predict the 
prescience of acute coronary syndrome in 3% to 79% of patients admitted to the emergency 
department with chest pain. The tool, on the other hand, has a high specificity indicating the 
ability to accurately identify a patient without the disease in 78% to 100% of cases. This 
confirmed the findings of the three GRACE studies (Lee et al., 2011; Lyon et al., 2006; 
Ramsay et al., 2007) which showed that the tool was able to correctly identify 466 patients 
with MACE and 5 358 patients without MACE. The HEART risk assessment tool shows a 
higher sensitivity than the GRACE risk assessment tool, but both are still low.  
From the sensitivity and specificity findings, it is clear that both tools are unable to accurately 
predict the prescience of acute coronary syndrome in a patient with chest pain due to the low 
sensitivity of each diagnostic tool. The strength of the tools is that they both have high 
specificity and therefore rather accurately diagnose a patient admitted to the emergency 
department without acute coronary syndrome. Both diagnostic tools might have low 
sensitivity and may not be able to accurately predict the prescience of acute coronary 
syndrome 100%, but individuals identified as positive for the prescience of acute coronary 
syndrome have a high probability of having acute coronary syndrome. This allows the 
treating physician or practitioner to safely discharge patients with low risk scores. This 
confirms the findings from Six et al., (2008:196) that a patient with a low risk score has a 
2,5% risk of developing MACE and can therefore be safely discharged. The researcher can 
conclude from the findings that both tools can accurately identify truly negative individuals 
with a minimal number of identifications being falsely negative. The findings also show that 
both tools can minimize the number of ‘missed’ diagnosed patients through identifying 
individuals with a high probability for acute coronary syndrome requiring further investigation. 
This confirmed the findings by Six et al. (2008:196) that a patient with a high score has a 
72,7% risk of developing MACE and these patients should be admitted and requires 
aggressive treatment. 
The results from the forest plot were used and plotted in a ROC space and an SROC curve 
was created. The SROC curve was used to allow the researcher to perform a comparison 
between the two risk assessment tools to determine which has greater predictor ability. Both 
tools proved to be informative when making a diagnosis as both SROC curves were plotted 
above the non-discriminatory line. Both the risk assessment tools showed that they had a 
predictive value greater than a random guess. This reinforces the findings from the studies 
by Yan et al. (2007), Yan et al. (2009) and Bajaj et al. (2013) which indicated that the risk 
scores were more accurate and superior to physician risk stratification. The GRACE SROC 
curve was closer than the HEART SROC curve to the upper left corner, the point known as 
“perfect” classification. This indicated that the GRACE risk score has better prediction ability, 
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therefore making the GRACE tool more accurate. The AUC was estimated using the 
traditional academic point system. The HEART risk score showed it had a probability of 70% 
to 80% of correctly classifying a patient with acute coronary syndrome. The GRACE showed 
it had a probability of 80% to 90% of correctly classifying a patient with acute coronary 
syndrome. When these findings were compared, the GRACE risk assessment tool proved to 
have a greater predictive ability than the HEART risk assessment tool. This finding was 
different from the finding reported by Fesmire et al., (2012:1830) which was that the GRACE 
risk score was outperformed by the HEART risk score. 
It is clear from the evidence of the sensitivity, specificity, SROC curve and the AUC that risk 
assessment tools are better than just random guessing. The diagnostic power of a test 
requires both high sensitivity and specificity to make it a good test; therefore one is not 
necessarily better than the other. The ideal with acute coronary syndrome is to have a test 
that has a high sensitivity to avoid missed diagnoses.  On the other hand a test with a high 
specificity does indicate that a positive result can be useful if one needs to rule whether a 
disease is present. The benefit of both tools are that they are very useful in emergency 
departments or general practitioner rooms when one needs to decide quickly on whether to 
admit for further investigation or to discharge a patient. Especially when research has shown 
that NSTE-ACS is more prevalent than STE-ACS. NSTE-ACS causes a lack of ECG 
changes and a lack of increased cardiac marker levels. Therefore if the HEART or GRACE 
risk score (which are both high in specificity) return with positive results, then there is a high 
probability of the presence of acute coronary syndrome. The HEART and GRACE risk tools, 
being more specific than sensitive, indicate that fewer non-diseased patients will go for 
further testing, thus reducing the waste of time and cost which is another great benefit. This 
will reduce the occurrence of the risk-treatment paradox described by Yan et al., (2009:376). 
The index tool will not replace current practice but will only improve current practice. 
The researcher recommends that current practice (which can be described as “random 
guessing”) should be supplemented with a risk assessment tool to improve the delivery of 
healthcare. The GRACE risk tool appears to be more effective and accurate in its prediction 
ability than the other tool, and it appears to be better suited, but in South Africa the GRACE 
risk assessment tool may not be feasible as it requires internet access due to difficult 
calculation of scores. Many of our rural countries do not have access to internet. Therefore 
the researcher recommends that the HEART risk score should be trialled in South Africa. 
The HEART risk score is a basic tool, easy to use and requires no calculator or internet 
access, this risk score can be used additionally to current practice. This risk score can assist 
especially in cases of NSTEMI and unstable angina pectoris when there is a lack of ECG 
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changes and lack of increased cardiac marker levels, but patient exhibits suspicious 
symptoms of acute coronary syndrome. 
 
5.3  LIMITATIONS OF THE STUDY 
Limitations are defined by Grove et al. (2013:669) as the restrictions, both theoretical and 
methodological, in a study that may decrease the ability to generalise the results.  
There were a few limitations identified during the study; these are detailed below. 
 Although the researchers performed a rigorous and broad search for articles, some 
articles could not be obtained for various reasons including restricted access or no 
publication available in an English version. All studies that could not be obtained, 
even with the assistance of a librarian, were documented and reported on in the 
results section including the reasons. 
 The quality of published data in two of the five included articles constitutes a 
limitation to the study. There was data missing regarding excluded participants who 
were not identified and no reason for exclusion was given. The researcher attempted 
to contact the authors per e-mail, but received no response. There was no pre-
specified index test threshold identified which also affected the quality of the 
published data. 
 Although the following is not a limitation as it did not affect the outcome, the 
researcher is required to report on software. In the initial protocol it was proposed 
that STATA software should be used for meta-analysis, as well as certain data 
analysis and synthesis techniques. During data analysis and synthesis however, 
Review Manager 5.2 software was used for the creation of forest plots and SROC 
curves and was found to be more applicable to the study results. 
 Both the described outcome and the reference standard identified in the protocol to 
be used in this study were adapted during the study. Because cardiac markers and 
ECG form part of both HEART and GRACE risk tools, authors of the identified 
articles used MACE as an outcome. This serves as indirect proof of presence of 
acute coronary syndrome. The researchers decided to use MACE as an outcome 
and reference standard for the study. 
 The HEART risk score was not researched and validated to the same extent as the 
GRACE risk score. 
 Only international studies were available, and the researcher had to interpret the 
findings and make these relevant to the South African context.  
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5.4   RECOMMENDATIONS 
An attribute of a systematic review is that it can help to provide recommendations for future 
research. The recommendations for this study are made for future research and nursing.  
The data analysis showed that there is currently no risk assessment tools used in South 
Africa. The evidence provided can now inform any decision on whether to implement the risk 
assessment tool in South Africa to form part of the diagnosing of acute coronary syndrome in 
adults. It is therefore recommended that, based on the systematic review done in this study, 
a risk assessment tool be developed or the GRACE or HEART risk assessment tool be 
modified and then implemented into daily practice. Developing or modifying the existing risk 
assessment tools and implementing them will improve the quality of care rendered to a 
patient with acute coronary syndrome. The researcher recommends a prospective protocol 
for hypothesis-testing study should first be performed before change in clinical practice can 
be justified.  
 
5.5   SUMMARY 
In this chapter the researcher discussed the results presented in Chapter Four and whether 
each set objective had been attained. The researcher answered the research question as 
stated in the first chapter. Limitations experienced during the study were identified and 
described. Finally, recommendations for future research were provided. 
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Appendix A: Ethics approval letter 
 
Ethics Letter 
15-May-2014 
 
Ethics Reference #: X14/05/007 
Clinical Trial Reference #: 
Title: Accuracy of acute coronary syndrome risk prediction tools: A systematic review 
 
Dear Mrs Johet Van Zyl, 
 
Thank you for your application to our Health Research Ethics Committee (HREC). This 
application is for a systematic review. 
The Health Research Ethics Committee considers this proposal to be exempt from ethical 
review. 
This letter confirms that this research is now registered and you can proceed with study 
related activities. 
If you have any queries or need further assistance, please contact the HREC Office 
0219389657. 
 
Sincerely, 
REC Coordinator 
Franklin Weber 
Health Research Ethics Committee 1 
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Appendix B: QUADAS 2 Tool 
 
Phase 1: State the review question: 
 
 Patients (setting, intended use of index test, presentation, prior testing):  
 
Index test(s):  
 
Reference standard and target condition:  
 
 
 
 Phase 2: Draw a flow diagram for the primary study 
 
 
 
 
Phase 3: Risk of bias and applicability judgments  
 
QUADAS-2 is structured so that 4 key domains are each rated in terms of the risk of bias 
and the concern regarding applicability to the research question (as defined above). Each 
key domain has a set of signalling questions to help reach the judgments regarding bias and 
applicability. 
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DOMAIN 1: PATIENT SELECTION A. Risk of Bias  
Describe methods of patient selection:  
 
Was a consecutive or sample of   
       patients enrolled? 
 
 
Yes/No/Unclear  
Was a case-control design avoided?  
 
Yes/No/Unclear  
Did the study avoid inappropriate    
        exclusions?  
 
Yes/No/Unclear  
Could the selection of patients have 
introduced bias?  
 
RISK: LOW/HIGH/UNCLEAR  
B. Concerns regarding applicability  
Describe included patients (prior testing, presentation, intended use of index test and setting): 
 
Is there concern that the included               CONCERNS:LOW/HIGH/UNCLEAR           
patients do not match the review 
question?  
 
DOMAIN 2: INDEX TEST(S)  
If more than one index test was used, please complete for each test.  
 
A. Risk of Bias  
Describe the index test and how it was conducted and interpreted:  
 
 
Were the index test results interpreted 
without knowledge of the results of the 
reference standard?  
 
Yes/No/Unclear  
If a threshold was used, was it pre-
specified?  
 
Yes/No/Unclear  
Could the conduct or interpretation of the 
index test have introduced bias?  
 
RISK: LOW /HIGH/UNCLEAR  
B. Concerns regarding applicability  
 
Is there concern that the index test, its 
conduct, or interpretation differ from the 
review question?  
CONCERN: LOW /HIGH/UNCLEAR  
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DOMAIN 3: REFERENCE STANDARD A. Risk of Bias  
Describe the reference standard and how it was conducted and interpreted:  
 
 Is the reference standard likely to correctly 
classify the target condition?  
 
 
Yes/No/Unclear  
 Were the reference standard results 
interpreted without knowledge of the results 
of the index test?  
 
Yes/No/Unclear  
Could the reference standard, its conduct, 
or its interpretation have introduced bias? 
 
RISK: LOW /HIGH/UNCLEAR  
B. Concerns regarding applicability  
 
Is there concern that the target condition 
as defined by the reference standard does 
not match the review question?  
CONCERN: LOW /HIGH/UNCLEAR  
 
DOMAIN 4: FLOW AND TIMING A. Risk of Bias  
Describe any patients who did not receive the index test(s) and/or reference standard or who 
were excluded from the 2x2 table (refer to flow diagram):  
 
 
Describe the time interval and any interventions between index test(s) and reference 
standard:  
 
 
 
 
 
 
 Was there an appropriate interval between 
index test(s) and reference  
    standard?  
 
 
 
 
Yes/No/Unclear  
 Did all patients receive a reference  
    standard?  
 
Yes/No/Unclear  
 Did patients receive the same    
    reference standard?  
 
Yes/No/Unclear  
 Were all patients included in the  
       analysis?  
 
Yes/No/Unclear  
Could the patient flow have introduced 
bias?  
RISK: LOW /HIGH/UNCLEAR  
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Appendix C: Cochrane data extraction tool (adapted)     
                             
 General: 
 
 
REF ID: 
 
Reviewer: 
 
Date: 
 
Checked by: 
                                         
Review Title: 
 
Author: 
 
Year: 
 
Country of Origin: 
 
Journal/Source of study: 
 
Publication Type:      ABSTRACT     /      FULL TEXT     /    OTHER (specify): 
Fate:         1.    PENDING    /     CHECK REFERENCE LIST     /       DISCUSSION      
                 2.    EXCLUDE STUDY     /       INCLUDE STUDY  /    DUPLICATION STUDY 
 
Notes: 
 
 
 
Methods:   
Study design: 
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Aim of study: 
 
Study Objectives: 
Methods of recruitment of participants: 
Inclusion/exclusion criteria for participation in study: 
Informed consent obtained?         Yes    /        No     /    Unclear 
Ethical approval:     Yes    /        No     /    Unclear 
Funding: 
Statistical methods and their appropriateness (if relevant): 
 
Participants: 
Description: 
Setting: 
Sample size: 
Age: 
Principal health problem or diagnosis: 
Time period of Study: 
Interventions: 
Details of intervention: (Tool used & Reference standard used): 
Details of control/usual or routine care: 
Delivery of intervention: (eg. stages, timing, frequency, duration): 
Details of providers: (Who delivers the intervention?; number of providers; training of 
providers in delivery of intervention): 
Intervention quality (if relevant): (Record any information on the quality of the intervention  
- assessed by study authors, others, or by): 
Fidelity/integrity: (Was the intervention delivered as intended? Record any assessment of 
this): 
Outcomes: 
Principal and secondary outcome measures: (as identified by the study authors): 
Methods of assessing outcome measures: (eg, phone survey, questionnaire, physical 
measurements) 
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Validity and reliability of outcome measures: 
Methods of follow-up for non-respondents: 
Timing of outcome assessment: (including frequency, length of follow up) 
Adverse events: (eg complaints, levels of dissatisfaction, adverse incidents, side effects) 
Notes: 
 Contact with author:   Yes (information obtained)   /      No 
 Study translated from a language other than English:      Yes    /      No 
Results: 
All data are numbers (of patients/units), not percentages. 
Dichotomous outcomes 
Outcome Timing of 
outcome 
assessment 
(days/months) 
Intervention group* Control group Notes 
Observed 
(n) 
Total 
(N) 
Observed 
(n) 
Total 
(N) 
       
       
       
       
       
       
Continuous outcomes 
Outcome Timing of 
outcome 
assessment 
(days/months) 
Intervention group 
 
Control group Notes 
*Mean/ 
Mean 
change 
Standard 
deviation 
N *Mean/ 
Mean 
change 
Standard 
deviation 
N 
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